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Tire Departmellt of Cell Biology and Plty.vioiogy sa/melt two r its most eminent personages
on lllrsday and Frida y, October 22 and 23, 1992. Carlton Cuyler " Cuy" Hunt, Ph.D .. (len)
nnd Albert Roos, Ph.D., were honored with a symposium that featured presentations by Pa ul
DeWeer, Mordecai Bla ust in, Denis Baylor and others , and the Erlanger/Gasser Lecture by
Nobe li 1 Bert Sa kmann. Hunt, who trained at Cornell, is renowned for having built thre
xce ll ent phy iology depal1m nts and for having trained many of the nation's most prominent
phys iology departmen t chairperso ns. He al 0 is known for hi s research into muscle ' pindl e ,
the small b d ies inside musc les that r gulate fin control. Roos rec ntly terminated the
National In tilutes of Health gra nt that had funded his lab without interruption since 1948,
mak ing it the longest ru nning grant on record. His work investi gating intracellular pH and
cell s of the carotid body that signal the bra in to control respirati on is internationally recog
ni zed . " He has been a leader in hi s department , a leader in his field . and a mentor to younge
facu lty," says de pa rtment head Philip D. Stahl. Ph. D .
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One mec hani sm by which critical ce ll s
in the pan creas are kill ed sets a new
direc ti on for diabetes researc h.
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1mproving Life's Quality
Researchers investigate a drug that alleviates the
pain of bone cancer.
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Good Data
Taki ng part in a study of th e ves tibular
syste m, the w rite r re co unts his ex peri ences
and hi s s mnll contributi on .
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A new linka ge map of the human
c hromo so me :: prov ides fo ur tim es
as many landmark s a s the pre vi ous
map. Co ordin a ted at the med ica l
school, the map co mpri ses d ata
fr om laboratories aro und the
wor ld . Th e g raphic interpretat ion
on the cove r is by Greg Mich ae ls.
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The human genomc is no long er un charted
territory  th e initi at ive to map it is wo rkin g.
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el wiil G. Kre bs, MD ,
a 1943 !ITauuate of'
th e Schoo l of Med i
cine, recc i\ ed the Nobel
Prize III Med icine on Octo
ber 12, 1992. for hi s researc h
into a reglila tory mechani sm
th at i ~ known to "con cern
al most all processes impor
t,1111 to Ii Fe;' [u;cording to an

4'~
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many hi olo" .ica l fu nctions in
a ce ll. T hose function:. in 
clude inn ammato ry reac tions
and the breakdo wn of' gl yco
gen 1I1to glucose , ::1I110 n~
lll any o th c r~ .
Krebs ' stuui c$
and re
.;cnrch based on his wo rk but
conduclcd by othl.:1" scienti sts
havc had a n impac t on
invl.:st igations into
subj ec ts as diverse
as tnlIl sp lantation.
endocrino logy. eal1 
I.:cr. growth and de
velopment and the
I lllm Un t

go lden .tge of biochemistry.
Krebs ~ h a res the Job I
P rill' wit h Edmond H .
risc her, M.D. T he two haH'
worked together fo r al most
40 years at the Univers ity or
Was hi ngto n in Seattle.
Kre bs has maintaineu hi s
l"l' latioll !>il ip with Washing
[0 11
nivers ity , choo l o f
Medi cine thro ug h the Yl.:a rs.
1k is a mem ber o f th e Eliot
Soc iety and has rece iv d
awards incluumg the
unive rsity' s D ist ing uish ed
Alumni Awaru in 19 72 and
th e medica l .;;eh lOt'S
Al umni Ac hieveme nt Award
in 19XX,

res pon se

tn addition to

Nobel Pr;:e wi//ll er Ed win G. Kreb::.,
1/ 1943 grad/WIt! oftlt e
Sd/()o/ of Medicine, researd/ l',\ en
:ymes (,l'lIlml 10 /1/ ( IfIY oflife ',\' pro
cesses. He sltares lite prhe wilh
E dmond H. Fischel', M.D. (Iejt). rit e
tll'O (f re fa clIl(~' members attlte U"i
I'ersity of WI/sltingtoll.
M.D. , (rig ht)

an nouncement by the
Ka ro[inskn Inst itute III
Stoc kholm . Sw den.
r he bioehelll iC<I I process,
first di scove red ill the 1l1 id195 0s, invo l e~ the c l a~s o f
enzymes - protei n kinascs
- that acti vate an d deacti
vate ce llular aC t! \ ity, reg u
lati ng ce ll m tabol ism. By
speeding li p th e chem ica l
bonding o f' ph osphoru s 10
proteins. k i na s ' ~ act a ~ \vhat
ha::. been ea li eu the " 1i fe
swi tch" that turn s o fT and on
2

being a graduat e of
the med ical schoo l.
Krebs. now 74.
com pl eted a re
searc h fell owshi p in
the schoo l's biol ogi 
cal chemist ry de
partment an d ~ef\'ed
hi s res idency in in
terna l med ic ine at
B rnes Hos pital.
Whi le a studcnL.

I It I ) ~ I.. I'.
t \, N .... fle.1
cti ng 011 referrals
from buil ding man
agers, family mem
bers. ncig hbors nnd cli nic
phys ic ians, the mcdica l

~ ch\lol - ~ 'v1emory and Aging
Project Satell ite is rcachi ng
out into the communit y to
help those wi th Alzhei mer' s
disease or other fo mls of
dcmenlia who otherw ise
wou ld rece ive no he lp Since
Lh ey bega n in June , Ihe
workers have idellti fied and
assis ted 43 people. none of
\\ hom had been diagllo~ed

rrc., IOllSJy .
Accord ing to p ojecl ui
rector Don thy Edwards.
Ph .D .. the tcam th at gue ' out
into Ih~ t:ol11ll1 un ity is ru nd~ u
by a ongr<!~s io nal <J rpro
prill ' ion designed 10 c:-.tend
the efl'.:cl iveness of 1Hof the
nati on's AILht:1l11Cr' S Di sease
Researc h C en ters. including
the (l il t; ltc re. The Illllu ing is
not fur r~s~arc lt , hUl fo r del i very \.) 1' what has been
learned and for addres ing
thc needs of l11 11lority and
med ica ll y un derservcd adu lts
- thosc iso lated or discon
nct: tcd from the syste m .
I he ou treach program is
uperatcd th rough Ihe med ica l

res ident and re
searc h fe ll ow in Sl.
LOLl i~. Krebs
worked under and was in fl u
ell ced by Washington

Uni versity' S 'arl and Gerty
of i. l1l)tcd biochemists who
themse lves received the 0 
bel PriLl!. T he Cori lab bas
now spawn ed e ight Nobe l
i ts: Krebs. Earl SUlherl<ln d.
Chns tian Dc Duve. Luis
Lcloi r, Art hur Kornberg.
Severo Ochoa and the Ca n .,
Fo r morc than a decad e. the
('o ri lab rece i ved recogni' ion
for its ground-brea king re
searc h tha t helped laullc h Ih t:

A field teum f or the Mem ory afltl ..l.f.f;IIg Project Satellite I'js 
il,~ S t. Lm/ill'um' wh o /I/(/.\' bel/efit f rom ' he pJ'Ogrlllll, p erforms
(III o/l-sile ~ cre(!lIillg, lakes fl social his,tol), (flld checks lite
potel/tilll dielll 's stt/illS with h ealthC't/re de/il'ery ~ysle/ll s.

schoo l's Program in ()ccupa
tional Therapy. in co ll abora
tion with SI. Lou is Regio nal
Medical Center, the city's
Department ofTTcalth and
the SI Louis Are a Agency
on Aging .
.[ he team has three core
member!", l\\ 0 soc ial worker"
and a nurse traincd by
Leona rd Berg, Iv1 .D.. and
John Morris, "1. D., oj' th,,'
AlzheImer' s Disease Re
!'earch Cen ter (ADRC) Ar
ter making an appo intment
with an individual re ferred to
them. team Ill e m her~ do an
Oil -site screen in g, take a so
ci al history and ch eck on the
cl ient's status with Medic aid
and other hea lthcme delivery
systems. " Eighty percent of
the peop le we've seen have
bee n Medica id eligible but
nlll Med icaid certifi ed."
Ed wards says .
The direct app roac h taken
by the satell ite e ffort bas
, hown its advan tages .
Edwards believes thatthc
in terven tion of lhe team aJ
rc:ady ha.-; saved al least two
lives, incl ud ing lhat ofa
woman. is(l I(;lted fwm tilt:
ystern. who wa ~ round in
he r dwell ing. starv ing.

'\ _Izlu'inu'.. 'IS
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esearchers at the
Schoo! or Med ici ne
Jrc investigating
how dri\'ing pertonllanl:C
chcmges wi th time and age
Cl nd how A ILhe imer's disease
may affee[ driving ab il Ity.
The study'S principal in 
\'est igator. John Morris,

M_D. , assoc ia te prof'es,or of
neuro logy, anu coprinc ipal
invcr; tigator. Linua Hunt.
instructor of occupatio nal
Iherapy, say the ir resea rch
will help determ ine when
patie ntr; wi th Alzhei mer's
disease shou ld sto p drivin g.
It .lI so will prov ide use rul
in fo rmation for e~ ta h lishi n g
public poli cy regarding driv
ing compete nc y and I iccnse
renc wal inten'al s for the
elderly .
"Often. the e lderly an d
their famil ies arc uncerta in
whether dr iving is im paired
and wheth er driv ing pri\ i
leges should be n:l in 
qu is hed," says Hunt. "This
st udy wil l help fa mil ies \vith
the dec isi on process."
The study . fund ed by the
ation al lnst ilute on Agi ng,
will c\ aluate hea lthy el derl y
driver!> a ~ well as drive rs
with very mild senil
dement ia or ihe All hcimn
type (SDA T ) and tbose with
mdd SDAT
Each sllIciy partic ipant
wi ll take a series of tests to
evaluate memo ry and cogni
tive fUllcti on and be asked
questi on s ab out how they
perceive thei r driv ing ability
In add ition. they wil l com
plete n onc-hour road tes t
and undergo a se ries o f nell
rol ugiea l. visual and motor
contro l tests at the Sl'hool of
'vfed icin e's Al7 heim er 's D is
ease Researc h Cen kr. Skill~'
sLl ch as mainta ini ng \' igi
lan ce, sw itching attention
and payi ng attenti on to mul
ti plc ac tiv ities will be !TIca 
., ured.

l inh « ' I'~iIY
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Fir!-il lJ(,hah:.

ith th e worlt!
important 90 minutes of the
watc hing. the fi rst
camp<l igll ." Fou hy later sai d
n<l ti ona lly tckviscd.
that all preparations had paid
three-person pres idential de
off and that the program had
bate in U.S. history was held
gone off perfcctly.
on the Washington Un iver
Even at that stage of th c
sit y camp us on Sunday
campaign, few people out
evcning. Ol: tober I I.
side stri ctly pJrtisan eirclcs
[ n a week -long llurry or
were willing to pwda im a
activi ty, 1Illi ver"ity sla rr
wi nner ort he debat e; each of
members prepared
the Athleti c
Compl ex 's Fie ld
I louse. trans form ing
it from a basketba II
court surrou nded by
bl e ac he r~ into a de
bate hall. Four net
work platforms
lVac co nst ructed at
one l'nd of the
cou rt. opposi te the
huge set that had
bee n buil l in New
York. dismantl ed.
Challcel/or William II. Dallforth.
th en tru cked to St .
M.D., alld Ed FOlllty. executive pm
Louis for 1he eve nt.
aucer of the p resil/ell till/ dehales jor
Approx imatel y
J 992, ll(/dreS!)' {J CNllI'd IlIlIIgry for ill 
1.000 members of
fOl'lI/flt;,,,, ahout (/el}(lle logistics.
the media received
the th ree can di datcs ap
crede nti als for the deba te
th at was broadcas t to wh at
peared preparcd and rela
produce rs estim ated to be th e
ti vely relaxed. cons idering
largest non -:; ports viewin g
the intense press ure.
Chancellor Willi am H.
au di ence ever. Only about
1.200 peo pl e - hal f of them
Danfort h call cu the dcbllle "a
mem bel'S of the prcss 
grea t thing for St. Loui s llnd
wc re accommodllted in the
a won derful thing l'or Wash
debate hall. A 1110ng [he total
ington Uni versity - a place
werc 250 Washington Uni
ded icated to debate. argu 
mcn t. hearing di rre rent opin
versity st udents, 140 oftl1 clll
ions. and. thro ugh all tha t,
sca ted on the fl oor of the hall
:.earcili n(C lor the tru th ."
and Ihc o th e r ~ admitted to
the press balcony .
The event 's producer. Ed
1'oul1y. refened to the fi rst
dehate as perh aps "the mos t

J
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hort-term memory 
the ability to recall a
phone number or
nam e for a short period of
time as needed - works best
whe n people silentl y re
11earse the information in
stead of trying to remember
what the words or numbers
look like, say resea rchers
here.
Recent research into read
ing disabilities Iike develop·
mental dyslex ia emph asizes
tIle importance of recod ing
visual information into a
speech-based representation.
These fi ndings on short-term

PET images reveal that
those who perform poorly
on short-term memory ((o k.\'
(top image) show increased
activation of the brain's vi
sual association cortex,
marked by the square box.
Good peljormers (bottom)
do not show that act;vtltioll.
Both groups sllo w activlltioll
of the slippleml'lIt(Jr), motor
area.
4

memory may have practical
applicat io ns as scienti sts
learn more about how the
brain contri buIes to dyslexia,
says Stev en E. Petersen,
Ph. D.
Petersen used positron
emi ssion tomography (PET)
to measure cba nge s in the
cerebra l blood flow of 12
volunteers as they performed
eitber a memory task or a
fixati on task. For thc
memory task, vo lunteers
were presented with five
words on a computer scrcen,
one at a time, prior to the
start of the scan. Each person
was instructed to try to re
member the five words dur
ing the 40-second scan while
staring at a small cross o n
the computer sc ree n. At the
end of the 40-second scan,
the volunteers were asked to
recite all the words they
could remember.
To e nsu re that the PET
scanner measured brain ac
tivity related solely to the
memory task, th e scan did
not incJude read ing the five
words and reciting the words
aloud . Subjeets also were
asked to stare at a sma ll
eross in the eenter of the
computer screen during
scanning to he lp control ex
traneous brai n activity. After
tIle memory task, contro I
images were made as vo Iu n
teei'S were scann ed while
staring at a fi xation c ro ss.
"When the brain activity
from the fixation is sub
tracted away, we see the
parts of the brain that change
in activity when the subjec t
tries to bold words in
memory," Petersen says.
Th e memory-fixation task
activated a right frontal area

and two motor areas, medial
s upplementary motor co rtex
( ~ M A) and left premotor
cortex.
Increased activity in the
first two motor areas and
decreased activity in an area
responsible for moutll move
ments suggc ~ t that subj ects
used a sile nt, internal
articulatory strategy to re
member the words, Petersen
says.
In a second study,
Petersen's group scan ned
subjects performing the same
memory ta s k as they tried to
remember pretend words that
followed the spelling rules of
English, like " floop." TIle
task activated the same areas
that were acti vated for
memory of real words, but
there also was activation of
an area responsible for atten
ti on, the medial anterior cin 
gu late.
Petersen separated the
subjects into two groups
ba . cd on thei r performance
in the nonword task: good
performers and bad perform
ers.
Those who performed
poorly showed increased ac
tivity in the visual cortex.
Good performers show ed
increased activ ity in the left
premotor area. "These re
s ults suggest that poor per
fo rmers used a visual
strategy in addition to an
articul a tory reh earsa l strat
egy to remember tbe item s,"
Petersen says. "We believe
that people who use on ly an
a rticulatory strategy to tem
porarily rememb er informa
tion will be more
succcssful. "
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cra ld M ' doff, M .D. ,
a nd Louis
SimchowitL
.D.,
ha \ been chosen to ftll two
new positions in the Depart
ment of Intern al Medicine.
Medoff, professor of medi
cine and molecular microbi
ology, ha s been named vice
chairman for clinical affairs;

Gerald Med(}ff; M.D.
Simchow itz , professor of
medicine and of cell biology
and physiology, has been
named vice chairm an for re
searc h affairs.
The appointments were
announ ced by John P.
Atkinson, M.D., professor of
medicine and molecular mi
crobiology. Atkin son be
came chairman of the
Department of Internal
Medicine on October 1.
More vice chairs will be
named in the coming month s ,
he says.

In hi s new post. Medoff
will manage clini ca l a ffairs
in th e dcpa lill1ent, fostering
a c1o !>l:r work ing relati onship
with Barnes Hospital. "Our
goal is to improvl: am bul a
tory serv ices to pati ents and
to utili7c the am bll iatory care
setting more effic iently in
the teachi ng program in
medicine. We also will try to
expa nd clinica l resea rch in
tbe department, wh ic h will
ba\ c direct appli ca bil ity to
improving patient care,"
Medo ff says. An importa nt

Loui,'l SiIll Cll oll'i (;., M .D.

goal of these ne\\- program s
VI ill be to train more physi
cians with an in terest in pri
mary ca re and in clini cal
research. he says.
As vi ce chai r. Medoff
will conti nu e his pa:; t in
vo lvement III the 4uality as 
surance program at Barnes
Hospi tal. He has served as
ch airma n of the hospi tal' s
in fect ion con tro l committee
since 198 1. In additi on, he
\\' iII co nduct research on

clini cal infec ti ous diseas';
and will remain co -direc tor
of th e di vision of in fec ti ous
d i:·, cClse.
Si mc howi tz wi ll coordi
nate resea rch aeti vi ties
within the departme nt. "One
of my gonls is to fos ter inter
acti ons among tb e medical
subspecia lti es in th e Depart
ment of Med icine and with
other basic sc ience depart
ment s throughout tb e uni ve r
sity," he says. His
respon si biliti es in clude initi
ati ng and deve lop in g new
rese arc h initi ati ves in the
fo rm of center grants, spe
ciali 7cd centers and program
projec ts in arc as such as ag
ing, ca ncer and genetics.
Simchowi tz will organize
effo rts to take better ad van
tage of fundin g opportun ities
from priva te foundati ons and
pharmaceui ;cal companies,
witb tbe aim of helpin g to
suppo rt resea rch by young
facu lty memb cIc, . lie in tends
to play an active role In as
sessi ng space and equipm ent
needs of th e department and
will partiCIpa te in recmiting
acti vtl ies .
Simc howit7 plans to co n
tinu e bis research aimed at
understa nding the phys i
ologic func ti on of hum an
neutrophils. blood cells th at
are important in inflamm a
ti on. J l i~ work has fo cused
on the role of intracellul ar
pH and calcium ion move
ment in neu trophil activa
ti on. In additi on, Simchow itz
has worked w ith ph arm ace u
ti ca l co mpanies to ex pl ore
new leads fo r developin g
ant i-i nfl ammatory drugs. ~
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ark E. Fri ssc,
M.D., has been
named assoc iate
de an for academic info llna 
tion ma nage ment and direc
tor of the Washington
University Schoo l ofMedi
cine l. ibralY and Biomedical
Communications Center.
He rep laces Susa n
Crawfo rd , Ph .D ., who
stepped down after serving
fo r II years as direc tor of
the library and bi omedI ca l
comm unications center.
Frisse 's appointment as asso
ciate dean for acad emic in
forma ti on management is a
new posit io n.
"Under Dr. Crawford 's
leade rship, our library and
bi omed ica l co mmunica ti ons
center bas beco me one of the
finest ," says W illi am A.
Peck, M. D. , vice chance ll or
for medical affairs and dean
of tbe Sch oo l of Me di cine.
"It is fi tting that we have
been abl e to attract som eo ne
with Dr. f ri ss e's outstanding
credenti als to succ eed Dr.
Crawfo rd . Dr. Frisse has a
trul y unique co mbin ati on of
talents - a first cl ass clini
ci<J n, teac ber, and co mputer
and informati cs scie nti st.
Our medic allibralY wil l be
we ll positioned to develop
and incorporate the most
mo dern information and
com munication services."
j' fJ sse ' s respon sibiliti es as
direc tor and assoc iate dean

Murk E. Frisse, M.D.
incl ud e coo rdinating medica l
center communications net
wo rks and inform ation man
agc mcnt fac il ities and
overseeing medi ca l comput
ing fac iliti es . He also is in
vo lved with information
management systems pl an
ning throughout tbe med ica l
center. For the past two
years, he has been direc tor of
the divisio n of med ica l in 
for matics in the Department
of Internal Medicin e.
Frisse and his colleagues
deve lop and evaluate bi o
med ic al infonnati on sys
te ms. Duri ng th e past four
years, he has de ve loped a
number of techniques to fa 
cilitat e the con structi on and
usc of large vo lum es of on
li ne tec hnic al mate ria L His
1110s t recent work in this area
inclu des thc develop me nt of
an electronic library system
and a method to cl assify L1 ser
info rm ation nl:cds. •
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Okhtar H. Gado,
M.D ., has been
nam ed as a fellow
of th e American College o f
Radi ology (AC R). The an
nouncemen t was mad e dur
in g the ACR annual meeting
held September 12-1 6, 1992,
in Phoeni x, AZ.

ACR is a national organi
zati on serv ing some 28,00 0
radio logists , radiati on
onco logists and radi olog ical
phys icists, with programs
focu sing on the practice of
radi ology an d th e deli very of
comp rehens ive radiol og ica l
hcal th se rvices.

._ I. 9 ~'rHiull
F'IIHI..; 11,"al"
Dj~. a..;p Sltuh'

Moklttar H. GIIt/O, M.D.
Selected for hi s outsta nd
ing contributions to th e field
of radi ology, Gado was
named as one of 144 new
fell ows by the college's
board o f c hancellors.
Fellowships in th e coll ege
are awarded to members for
s ignificant sc ie ntifi c or clini
cal resea rch in the field of
radiology or significant con
tributi on s 10 its litera ture.
Cri teria for selection also
include performanc e of ou t
standing se rvic e as a teacher
of radiol ogy , service to orga
ni ze d medici ne and an out
stand ing rep utation among
coll eagues and th e local
co mmunity as a resu lt of
long-term superi or se rvice.
6

he School of Medi
cine has rece ived a
$ 1. 9 million contract
from the National In stitutes
of Health (. [H) to coordi
nate a multi-center st ud y of
healt di sease in nearly
15,000 families. The stud y is
de signe d to help explain how
a person's genes and family
envi ronment work together
to ca use heart disease, the
nation '~ number one kill er. It
w iII be the first resea rc h to
examine both fac tors to
gether com prehe nsively in
such a large group.
Th e four-year contract ,
from the NIH 's 1\ati ona l
Heart, Lung and Blood Insti
tute, is part of an $ 1 j million
co llabora ti on among fi ve
universities. Washington
niversity will coordinate
th e stud y and analyze data
gathered by in vestigato rs at
the four field ce nters located
at Boston Uni ve rsity, the
Uni vers ity of Utah , the Uni
versity of North Caro lin a at
Chape l Hill and th e Uni ver
sity of Minne sota. Co -pr inci
pal inves ti ga tors Oabeeru C.
Rao, Ph .D ., pro/(;ssor and

direc tor of the di vision of
biostatistics, and Mi chae l A.
Pro vince, Ph.D. , assistant
professor of biostatistics,
will lead th e St. Louis team .
In th e past, most heart
disease studies ha ve looked
at the roles of ge nes and
lifestyle separately, says
Pro vinc e. Bu t, " If yo u want
to und ersta nd why it is that
hea rt disease tends to cluster
in families, you need to
study genetics and env iron
men t together. In real.ity,
heart dis ease is a very com
plex com bina ti on of both,"
he says.
The St. Louis team will
loo k at fa mily relationshi ps
to determine wheth er simi

larities among fam il y mem
bers are due to shared genes,
shared habits or both, Prov 
in ce says. For exampl e, be 
ca use identical twins have
the same ge netic matel"ial,
any physic al di ffere nces be
tween them must be due to
th eir environme nt ; on th e
other hand, adopted family
members share an en vi ron
ment, but not genes, he ex 
plains.
Researche rs will keep
blood samp les to create a
storeho use of ge netic infor
mati on. Geneticists wiII use
the storehouse to evaluate
newly identified genes that
might be important to healt
diseas e, Prov in ce says.

n 1992, for the twenty
second consecutive year,
stud ents at Wa shi ngton
Uni versity School of Medi
cin e have be nefi ted from
sc ho larships granted by th e
So uthern Medical Associa
ti on (SMA).
The SMA, a regional or
ganization comInitted to
bringing physicians together
by prov idin g fo r their profes
siona l and personal ne eds,
thi s yea r provided three
scholarships for medica l
sc hool stud ents, th e max i
mUIn numb er allowed for
anyone sc hoo l.
First- yea r students Adam
C. Eaton, of Missouri ,
Dionne A. Skeete, of
Florida, and Cathe rin e J.
Stocklin , of Texas, each re

ceivcd a $500 sc holarship to
he lp defray the cost of tu
ition . Ap pli ca ti on is mad e by
the ass ista nt dean for student
affairs on behalf of st udents
with superior abilities who
will benefit from tuiti on
ass istanc e.
Washington Uni ve rs ity
Sch oo l of Med icine stud e nts
have been fortunate to re
ceive scho la rships from the
SMA each yea r since the
prog ram began in 1970, and
each yea r the maximum al
lowab le number of students
has been named. According
to John F. Walters, assistant
dea n fo r student affai rs, a
total of 36 stud ents has now
received SMA sc ho larships,
and the aggregate of the sup
port is now $20,000.
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he surgical "cure"
for cancer of the
tongue, called a
glossectomy, ofte n costs pa
tients their ability to spea k
and eat, but a new techn ique
pioneered by surgeons at the
medical school is c hangin g
that.
In patients studied to dme,
the surgeon-researchers have
replaced cancerou s tongues
with skin and muscle flaps
harvested from the back.
Bruce Haughey, M.B. ,
eh.B., assistant profcssor of
otolaryngology and director
of otolaryngology at Jewish
Hospital , says the surg ica l
techniq ue 110 Id s grea t prom
ise as a treatm ent for oral
cancer patients .
One case involved a 13
hour operation at Bames
Hospital during which doc
tors removed tbe diseased
tongue, floor of the mouth,
nodu les on the neck, and a
piece of the patient's lo we r
jaw. Th ey then harvested a
flap of skin and muscle from
near the left shoulder blade,
crafted it into the shape of a
tongue, connected the blood
vessels and nerves, and
sewed it into the mouth.
"We ' ve done a fair num
ber of patients with this tech
nique , and the ti ss ue transfer
has worked very well,"
Haugh ey says. "We harvest
the tissu e from a donor
muscl e called the latissimus
dorsi. Th at's a muscle with
sk in overlying it as well as

associated vesse ls and motor
nerves ."
The cho ice of the latis
simus dorsi flap is what
makes thi s procedure unique,
says John Fredrickson, M.D.,
Lindburg Professor and head
of the Departm ent ofOtolar
yngology. "We need suffi 
cient bulk from the ti ss ue. It
must fill a large vo id in the
mouth. Th e flap also mu st
have a muscle to replace the
tongu e muscle, a nerve that
can be joined to the tongue
nerve and a good artery and
vein so the tissue can be
revascularized. This flap
mee ts all of those criteria."
Speech pathologist Den
nis Fuller, Ph.D., assistant
professo r of o tolaryngology,
rehabilitates patients whose
tongu es have been replaced.
He es timate s their intelligi
bility of speech at better than
85 percent following sur
ge ry. Several can talk on the
phone, and so me have re
turned to work.
As important as speech
and articulation are to survi
vors of oral cancer, talking is
only ha lf of the equation. As
Hau ghey says, "Not long ago
the method of treatment was
to remove the cancer and just
sew up th e patient - lea ve
them with nothing there .
Anything we can accomplish
with this new technique is a
vast improvement becau se
without a tongue, not only
can people not speak, th ey
can't swal low. That mea ns

they have to be fitted with
feeding tubes for the rest of
their liv es."
Th e success rate for the
ton gue replacement grafts is
more than 80 percent, with
the only failures coming
very ear ly in the se ries.
Fredrickson and Haughe y
look forward to the possibi 1ity of tongue transplantation
in the future. Nerve and vas
cular graft techniques could
make it possible for tongues

transplanted from cadavers
to restore not only speech
and swa llowing but also tac
tile sensa tion. First, how
ever, researchers must
overcome problems with ti s
s ue rejec tion , since cancer
patients often are not good
ca ndidates for the immuno
suppressive medication s
given to prevent rej ection of
transplanted tissue.

l(n..~n1t·V(~I· Nalllf·.1
tanley J. Korsmeycr,
M.D., has been nam ed
chief of the newly
formed division of molecular
oncology sponsored by the
Depa rtments of Internal
Medicine and Pathology at
th e School of Medicine.

Stanley J. Korsmeyer, M.D.
The appointment was an
nounced by John P
Atkinson, M.D. , chairma n of
the Department of Internal
Medicine, and Emil Unanue,

Dhi~joJl

Chief

M.D., cbairman of the De
partment of Pathology. As
chief, Korsmeyer will be re
spo nsible for fUl1h er devel
oping a research program in
ca ncer biology in those de
partments .
Molecular oncology is
one of two divisions created
in the Department of Medi
cine as an expan sion of he
matology and oncology
programs. Atkins on ,
Korsmeyer and Timothy
Le y, M.D. , assoc iate profes
sor of medicine and genetics ,
will head an effort to choose
a clinical chief for th e sec
ond division , medical oncol
ogy.
Korsmeyer plans to con
tinue his research a imed at
understanding how genetic
abnormalities lead to various
forms of leukemia and
ly mphoma. Hi s work focuses
on the role genes play in
early deve lopm ent of the im
mune system's T cells and B
cells.
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t ll1ight be viral. Perhaps environmen
tal or dietary factors playa role. The
cause is still shrouded in mystery, but
somehow, a pathogen fi nds its way into the
pancreas -

In Mid-pursuit,
Researchers Take A
Giant Step Toward
Curing Diabetes

the halIDner-shaped cluster of

tissue responsible for n1any digestive func
tions. The pathogen locates a parti cular
spot -

a knot of fibers and b lood vessels

rnarked by sl11a11 tubes and pit-like inden
tations. Called the islet of Langerhans, th i s
bundle of granular endocrine cells is the
part of the pancreas that produces insulin ,
the protein that allows the body to digest
and process sugar.
8

by Jim Dryden

Miclwel McDaniel, Ph.D. , (lef t) and John Corbett, Ph.D., (right) explore the possibility of blocking the effect of lIitric oxide
iIlSlIlill-PI'Ol/lIciflg cel/s of the pancreas as a means for treating diabetes. Wielding the pipette is research Ils.\·i.\'I{j1l1 COllllie
Ma rshall.

The pathogen might bind to ce ll s
wi thin the is let , but perhaps it simpl y
waits. It has not in vaded unnoti ced. Th e
body ' s immune system di spatches its
force s and attacks. The first comb atants
in th e fight are the activated mac roph
ages , cells that protect the body aga in st
in fec tion. Trouble is, they al so can
initi ate a process that kill s som e of th e
mos t important cells in the isl et, th e beta
(13 ) cells that secrete in sulin . Th e
acti vated lllacroph ages se t in moti on a
process that e ventu a lly results in
ju venile, or Type I di abetes.
Exactl y w hat cau ses th e process to
begin is unknow n. Variou s poss ibiliti es
have been consid ered, from in fe cti on 10
cow 's milk, but in th e laboratory of
Michael Mc Daniel, Ph.D. , in ves tigators
are studying what happ ens after that
triggering event ha s take n place.
McDaniel and hi s colle agues recently
identified what th ey beli eve may be the
cellular mechani sm that app arently
di sables and the n kills 13 ce ll s. The y also
ha ve some ideas about how to inhibit
that mechani sm. A co mpound called

aminoguanidine can stop and , in some
cases, re verse the process of [\ cell dea th
once it begin s.
McDaniel , professor of patho logy,
and John Corbett, Ph .D. , post-d oc toral
fellow in pathology, are at th e fo refront
of an effort to id enti fy th e su bstance that
targets and selectively kill s islet [\ cells.
That effector molecul e appea rs to be
nitric oxide.
"That's nitric oxid e, not nitrou s ox
ide ," McDani el pati entl y points out.
Nitric oxide is a hi ghl y rea cti ve mol
ecule comprisin g a sin gle atom of
nitrogen and a sin gle atom of oxygen .
Nitrous ox id e, on the oth er hand , ha s
two nitrogen atoms. Th e latter chemical ,
commonl y call ed laug hin g ga s, can be
breathed for lon g per iods of time with
little lasting effec t; small amounts of
nitric oxide can be leth al.
Nitric oxid e is a highly reactive
molecule. Nitrogen atoms have seven
electrons, oxy gen ei ght. That leaves an
unpaired electron. Because electrons
tend to form pairs, nit ri c ox ide reacts
rapidl y. As a res ult , it usuall y disappears

01/

from the sys tem quic kl y. Th e molecule
pla ys a ke y role in neu ronal communica
tion s and blood press ure regulation. It
al so appears to be a n age nt used by
immun e cells to des troy pathogens. Until
recentl y th ere wa s no way to demon
strate the presence of a hi ghl y reacti ve
molecul e lik e nitri c ox ide in the bod y.
In 1986, McD ani el heard Danish
research er .lorn Ncrup spe ak at a
meeting of the American Diabetes
Associati on. Nerup proposed cytokines
- substance s such as interleukin- I
(lL-I ), interfe ron and tumor necrosis
factor - as maj or culprit s in the course
of T ype I di abetes. McDaniel's lab soon
fo cused its resea rch on the role of
cy tokin es and on TL- l in particular.
"We kn ew th at IL-l wa s inducing a
new protei n in th e islet. We just didn ' t
know wh at th at protein was: ' McDaniel
says . He also knew that islets treated with
IL-l did not secrete insulin as well as
untreated islet cells. Though he could
prov e the bad effects ofIL-l were
medi ated by a protein or proteins, findin g
th e protein took another few years.
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A healthy islet cell (top lep)
contrasts sharply with one de
graded aper being treated with IL
l for four days. Inhibition of nitric
oxide formation prevents the
destructive effects of lL-l 011 islets
(bottom right).

IL-1~

In 1990, when John Corbett joined
the lab as a trainee, the research took its
next step . "We didn't have an idea of
what protein was involved," McDaniel
recall s. "John proposed we look at nitric
oxide synthase."
Nitric oxide synthase is a protein, th e
sole purpose of which is the production
of nitric oxide. Research in 1990 had
shown nitric oxide could produce effects
on targe t cells s imilar to those caused by
IL-l on the f3 cell, so Corbett and
McDaniel began there. Because of its
high reactivity, nitric oxide is hard to
find in its free radical form, so the
investigators attempted to locate the
protein in stead. They also looked for the
byproducts of nitric oxide production.
Becau se they knew lL-l inhibited
insulin secre tion and ultimatel y de
stroyed f3 cells and suspected that nitric
oxide synthase was the protein in vo lved ,
McDaniel and Corbett treated their
cultures with both l L-l and with
compounds that block the pathway
through which nitric oxide is released as
a free radical.
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+ 0.5 mM NMMA

The best-known inhibitor of nitric
oxide is N-monomethylarginin e
(NMMA). When they treated rat islet
cells with NMMA and IL- I, the cells
continued to secrete insulin normally.
Without NMMA , insulin secretion
slowed , and the cells eventually died.
" 1 think it ' s pretty well estab li shed
that the macrophage is a so urce of nitric
ox ide, but if the macrophage continues
producing high levels of nitric oxide,
and if nitric oxide is freely permeating
all cell membranes, it's going to diffuse
into every cell in the proximity," Corbett
explains.
Th at would result, he says, in the
death of other cells in the islet. Instead,
their data show that after a short pulse of
nitric oxide from exposure to IL-l, the 13
cells themse lves take over. Says
McDaniel , " Nitric oxide is either
speci fic because the 13 cell is more
susceptible (and that's possible), or
because the 13 cell can produce nitric
oxide and selectively destroy itself."
The goal of potential therapies is to
prevent 13 cell death. Intervention could

come at any point in the disease process,
but one way might be to treat the ce ll s
with an inhibitor of nitric oxide
synthase, McDaniel says. It is possibl e
to block th e process by treating f3 cells
with NMMA, but there are major
problem s associated with that stt"ategy.
Nitric oxide plays many roles in the
body. One of its impot1ant jobs is as the
so-called EDRF (endothe lial-deri ved
relaxing factor). DRF regulates blood
pressure. Endothelial ce lls release EDRF
- actually nitric oxide - Wllich
induces the relaxation of smooth muscle
cells that line blood vesse ls. Block nitric
oxide with NMMA and blood vessels
constrict, causing blood pressure to rise.
Blocking the nitric oxide pathway also
can cause problems in the synaptic
transmission of certain neurons.
"Nitric oxide has both a physiological
and a pathophysiological role. It 's
almost like IL-l. Under some circum
stances, IL-l is impOt1ant in the immune
system. In another situa tion , under
conditions where you have it in the
wrong place at the wrong time, it's
hannfu!' . litric oxide works the same
way," McDaniel says.
Therapies require that the production
of nitric oxide be shut off in the pan
creas without shutting it off in other
parts of the body. It turns out that is
possible because nitric oxide syn thase
comes in two isofonns. They are called
the inducible and the constitutive
isofo nns . The constitutive isofonn of the
protein manufactures low levels of nitric
oxide for blood pressure control. It is the
inducible isoform that is produced by
macrophages and other immune cells.
The constitutive isofoml is always
there in certain cells. Th e inducible
isofonn, as the name suggests, is not
expressed unless a cell is exposed to the
appropriate cytokine. "Th e f3 cell is
capable of expressing the inducible
isofo lln of nitric oxide sy ntha se,"
McDaniel says. "That means if you can
block the inducible isoform and ignore
the constitutive, you can stop the
mechanism of diabete s without creating
problems elsewhere."
That is exactly what McDaniel and
Corbett have done. Tiley discovered,
working with Joseph R. Williamson,
M.D., and Ronald G. Tilton , Ph.D. , th at
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The top figure shows the process
within a cell as nitric oxide interacts
with iron sulfur centers of iroll
containing enzymes. A stable complex
that can be observed by e.p.r. is the
result. Theformation of these com
plexes is shown in the lower panel_
Treatment of islets with IL-I results in
the generation ofnitric oxide com
plexes highlighted here. NMMA
prevents the formation of this complex.

same way it works in McDaniel's lab,
and it could be several years before it is
used in clinical tri als to test its ability to
stop f3 cell death. McDaniel and Corbett
have shown that it work s, but it may be
years before scientists understand Why.
Both McDaniel and Corbett believe
that question s requiring an swers prior to
clinical trials deal more with the timing
of therapies. "There are variou s predic
tors that people are studying. They're
looking for the presence of insulin
antibodies, islet cell antibodies, that are
thought to provide some evidence that a
person may be developing Type T
diabete s. We need to clarify what those
indicators are , and th at will give us a
better ide a of when to give amino
guanidine to treat people who are
developing diabetes," McDaniel sa ys .
In recent experiments, Corbett and
McDaniel have used electron paramag
netic resonance (e.p.r.) spectroscopy to
demonstrate the presence of nitric oxide
in the cells. Earl ier research predicted
the presence of nitric oxide by locating
th e building blocks of th e free radical

and then finding its after-effects. The
e.p.r. images alJow the investigators to
look at the molecule during the few
seconds of its brief life.
"The e.p.r. image is our direct
evidence for the presence of nitric
oxide ," McDaniel says. With e.p .r. , the
investigators no longer hav e to operate
on assumptions. A detective who sees
shoes and a full ashtray might ass ume a
person ha s been in the room, but with
e.p.r. "we ' ve measured not only the
presence of the shoes in the room,"
Corbett says. "We've also measured the
person in the shoes ."
Fourteen million American s have
diabetes, but with luck it may end there.
Much work must be done on the journey
to a cure, but Corbett and McDaniel are
now leading th at research in a new
directi on. They have identified not only
the mo lecule that may be involved in the
disease but also the compound that stops
it. They tru st fewer miles are left to
travel than they have come so far, but
how much research is left remains
unknown . •

j3-cell

Islet Insulitis
--............. Protein Synthesis

aminoguanidine blocks the formation of
inducible nitric oxide synthase. Unlike
NMMA and other inhibitors, amino
guanidin e does not significantly inhibit
the constitutive isofonn of the protein.
"The process of f3 cell destruction
goe s on for a while," Corbett says. "You
may lose 40 percent of your f3 cells but
see no effects on blood sugar. The key is
to provide therapy before the process of
Type I diabetes ha s measurable effects,
halt it, and perhaps even reverse it."
In early experiments, McDaniel and
Corbett have used aminogu anidine to
successfully halt the process of f3 cell
death. The y have te sted aminoguanidine
in a rat model, a mouse model and in
human islet cells. It does the same thing
in all of tho se experiments.
Data from trials suggest that
aminoguanidine can be gi ven to people
safely . But there is no data on whether
aminoguanidine works in people the
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Mitochondrial Damage
In the mechanism by which jl cells are destroyed, macrophages release IL-I, which
binds to a receptor on the jJ cell and triggers a series of events leading to one form
of nitric oxide synthase (iNOS). This enzyme catalyzes the production ofnitric
oxide, which impairs function in the mitochondria ofjJ cells. The researchers
believe mitochondrial damage results in jJ cell death. Activated lIIacrophages also
produce high levels of Ilitric oxide that may contribute to cell death.
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omeday, there may be a movie
theater you can visit - screens and
~ tereo speakers surrounding you 
where, for the price of admission,
you can tour the human genome as if
you were traveling along its length on a
virtual railroad. As your car rolls along
the double helical rails that span the
genome from chromosomes I through
22, landmarks along that vast roller
coaster of information tell you where
you are.
Imagine rolling over stretches of
DN A, speeding on sections of rail that
represent genes. As you whiz down the
twisting track, places with names like
"p53," "APP," and "cystic fibrosis
locus," jump out at you. Someday such a
tour may be possible, even a routine part
of elementary school education. For
now, though, the railway is still under
construction, and it will be awhile before
scientists fill the genome with land
marks.
The Human Genome Project proceeds
full steam ahead toward that goal. Like
once virgin Antarctica, the human
genome is now studded with landmarks
- more than I ,400 at last count. And
scientists continue to map uncharted
territory at a fast pace. This year,
researchers affiliated with the genome
project have published several milestone
papers that offer new maps of the
genetic railway that lies within each of
our cells. The maps are getting better
and more informative, and they will
undoubtedly assist in the discovery of
disease genes, says professor Helen
Donis-Keller, Ph.D., director of the

S
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AN IMPROVED ~1AP
OF THE GENONIE
PROVIDES INCREASED
RESOLUTION

BY JIM KEELEY
division of human molecular genetics,
Department of Surgery.
The genetic linkage map is one type
of gene map that has proven useful in
tracking disease genes. Donis-Keller's
group at the School of Medicine is
building linkage maps of six chromo
somes, nearly one-third of the genome.
A linkage map of a particular chromo
some shows the location and order of
key markers  actually unique pieces of
DNA  that scientists can use as
"mileposts" or landmarks in locating the
position of various genes.
But the marker isn't the final quarry
in this hunt; disease genes are. Donis
Keller explains: A genetic marker (also

referred to as a locus) is a D A se
quence on a chromosome that varies
from individual to ll1dividual. It is this
difference that allows the tracing of the
chromosome segments from parents to
children, from generation to generation.
Each difference found at the marker is
called an allele.
"What we look for ll1 genetic map
ping of disease genes is the co-inherit
ance of the same alleles and the disease
trait in families that are passing the
disease along," she says. The rule is that
the more commonly the gene and the
allele are inherited together, the closer
they are on the chromosome. "I n this
way, we find out which markers are
close to the disease gene," Donis-Keller
says. "Once we find linkage of a disease
gene to a particular marker, we test other
markers from our map that are in the
general vicinity so we can bracket the
disease gene on the chromosome. Then,
we begin combing the area of the
genome between the markers, looking
for the disease gene itself."
This method has proven highly
successful. Geneticists using the
technique have found many genes,
including those responsible for cystic
fibrosis, muscular dystrophy,
neurofibromatosis, a form of colon

The mapping team of Helen DOllis
Keller, Ph.D., includes (clockwise, from
noon) Donis-Keller, Tammie Repko,
Todd Steillebrueck, Li Liu, Ralph
Normington, Mary Akin and Cindy
Helms. On the table is the indispens
able FAX machine.

cancer, and an inheritab le, early-onset
form of Alzheimer's disease. " Improved
linkage maps are respon sible for getting
us closer to ge nes that some people
never dreamed we'd find, like breast
cancer and dlabetes," Donis- Keller says.
Putting together a linkagc map of the
entire ge nome is not ea sy. But Helen
Donis-Keller and her crew know how~
they no w have constructed two . The fl rst
linkage map of th e entire genome was
published in 1987 by Donis- Ke ll er and
sta ff when 'he was at Collaborative
Research . Inc ., a Massachuse tts biotech
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The lil/kage lIU1p of dlromosome J
iI/dudes a gruphic: repre:>el/tatiIJI/ of its
characteristic bal/dillg, with the btllllis
/HIII/berelloll the right, To the leji are
'he sJ'lIIbol,~ for the i"dil'idlflilmurkers.
The smaller /llImbers slim" til e disltlllce
betwee" the //lurkers il/ cel/riA-lorgans,
where olle centi,Wor{flill equals ilp
proximately J milliOl/ base pair '.
IlIwllosome I hi huge, equal to 10
perc:ellt of the Kellome.
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nology company. That map had about
400 markers and wa s useful in locatin g a

number of di sease genes, including one
for an inh erited form of heart disease.
By today ' s standa rds, thou gh. the 1987
hnk age map scems pnml tive. Sti ll.
Donis-Keller belie ves publishing that
map gave the Human Genome Proj ect a
much-needed boost.
In 1991, scientists funded by gran ts
from th e Nationa l Center for Human
(ienome Research (NCHGR) decide d to
publish an updated genetic link age map.
The commi ttee advis ing Nobel laureate
James D. Watson, then director of th e
Human Gen ome Project, suggested that
the map should be published as quickly
as possible. Not to be outdone, French
scie nti sts at the Centre d 'Etud e du
Polymorphisme Humain (CE PH) in
Paris said that they would publish a
se parate genome map.
Concerned that two Iinkage maps of
the human ge nome would be confusing.
thc C . PI{ scien ti Is and those ii'om the
NCHGR agreed to co mbine thei r data
and produce a single ge nome map. But
which lab would take on the monstrou s
task ofa ~ se mbling the data into a
cohesive, publi shable manuscript? The
committe turned to Donis-Kell er and
her battle-tested colleagu e~ in t. Loui s.
In early October 1992, th<.: most
co mprehensive, up-to-date linkage map
of the hum an genome rolled off the
presses at the journal Science in ash
ington, D.C. The manuscript contained
mapping informa tion from 129 sc ienti sts
in 70 labs in the United Stales, bt rope,
Japan, Australia and South Africa. It is
reported to bc th e longest resea rch
article ever published by Science.
As the deadline for submission of the
manu script drew near, Do ni s-Keller and
her staff tran sformed their lab s and
offices into a communications center
th at wo uld be the envy ofCNN "Seven
peop le in my group wo rked night and
day, including weekcnds, compillllg the
data ," Doni s-Ke ll er says. "Tbis project
would not ha ve happene d if we didn't
have their cooperation and wi llingnes s
to work."
Th roughout much of the summer.
primary data poured into Doni s-Kelk ( -'
lab from as fa l' a\.vay as Johanne sburg,
London and Tokyo. and the group
worked to piece togeth er the map in

XMarks The Spot
hen g neti ci. ts fi rstthollght
seri o.usl Y o f map ping the entire
human genome, the looming
questi on was wh eth r such a
huge undertaki ng was actually possible.
Could the technol ogy be deve loped to
ana lyze every bi t of all individual 's
genetic informatio n? ould the data be
mana ged? After five years, " there's no
longer any do ubt: ' cays David
Schl e!)s ingn, Ph D. "The Genome
Initiative is working ."
Schlessi nger, profes sor of molecular
microbiology, lead. the Ge nome Center
here that is aiming to produce maps of
both chromosome 7 and the X chromo
some. In the cen ter, Eric Green, M.D. ,
Ph.D.. leads the 7 k:lm; Ph il Gree n,
Ph. D., has directed th necessary
software developmen t. an d Schl essinger
leads the X team and coo rd inates the
overall c ffort.
The X team's work was til slIbject of
an arti cle anu a "cente rfol d" in the
Octob r 2 iss ue of Sciellce. Along with
other researc hers :lround the world, the
team is build ing a map of the X chromo
som e they call a "unified . genetic,
physical and func tional map."
Schless inger expla ins: "T his map
incorporates Iinbge in f01111a ti on about
where di sease genes are located based
on fam il y studies. Bli t linkage informa-
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COlTcc t ord er. The data for the maps
werL~ sent by elec tronic mail or on
comp uter di skettes . Edi ted and rewritten
where necessary, they \\·ere L1sed to uraw
graphic maps and form attcu into tables.
"A rter we sc nt the first draft to th e
129 collabo rators, we received th e first
wave of corrections ," Donis-K eller
reca ll s. More phone calls and FAXes
ensued to ciear up ambi gui ti es and
re4uest miss ing data. "We si mp ly could
not have completed this project on time
without a FAX mac hinc." Doni s-Keller
sa s. " My phone bill look s like the
national deb t." : he jokes. Bu t the
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David Schles.~illf(er. Ph.D .. with his hllt
of a different me(millg.

tion is sparse. I f the chromosome were
the United States, it could tell you that
what you're interested in is in Missouri.
The physical map of the X chromosome
is more detailed and locates genes of
interest in a more definite area - in
analogy, in Forest Park in St. Louis."
Inten se work on the X chromosome
has resulted in the identification of 225
genes, I J I of which are disease-related,
by far the largest number for any
chromosome. Included among the
disease-related genes found are those for
retinitis pigmentosa, chronic
granulomatous disease and Duchenne
muscular dystrophy.

tion was a necessary task; the slightest
error would make a major difference to
the geneticists who will use this map as
a research too I.
A draft of the paper was finally sent
to each participant for comment. On
August 8, a few days later than she
wanted, Donis-Keller went to Washing
ton, D.C. . to deliver the manu script to
Science' s editorial offi ce in person.
The worldwide team of genetici sts
mapping the genetic code is about half
way to its final goal. The aim is to pro
duce a map with markers spaced no
more than J million base pairs apart. The

More is known about the X chromo
some than any other, probably because
of interest in di seases linked to genes
located there and because of the charac
teristic inheritance pattern of X-linked
diseases. Males have only a single X;
females have two. The result is that
recessive diseases are revealed in males
who carry the defceti ve gene as their
only copy.
About 40 percent of the X chromo
some has been mapped in DNA recon
structed in overlapping, aligned
fragments. Schlessinger and his col
leagues have brought two technologies
to bear on the work. The first was the
use of Y ACs, or yeast artificial chromo
somes, that allow the isolation of large,
discrete pieces of DNA that can be
overlapped to reconstitute the whole
chromosome
the "map." The second
innovation is the use of sequence tagged
sites (STS) , each a string of the base
pairs that make up DNA Jong enough to
be unique. When two large YACs
contain the same tiny STS , the mapper
knows that they overlap at that STS
sequence and is able to piece them
together in order. This simple but
powerful concept, originated here by
Maynard Olson, Ph.D., and Phil Green,
now organizes the work of the interna
tional mapping community.
One goal of the Genome Initiative is
a map or every chromosome with STS
markers at an average placement of one
every 100,000 base pairs. For the X
chromosome, that work s out to a total of
1,500 markers arranged along the 150

human genome con sists of roughly 3
billion base pairs, s panning 22 chromo
somes, plus the sex chromosomes X and
Y. A quick calculation shows that the
team's goal is to find about 3,000
reliable markers.
At the time of publication in Scien ce,
researchers had uncovered 1,416 unique
snippets of genetic material useful as
markers. That is about four times as
many markers as the 1987 map had ,
Donis-KelJer says. More importantly,
scientists are finding markers at a faster
rate, and those they find are generally
more informative, she says.

miJJion base pairs of the chromosome.
(To do all the chromosomes at that Jevel
of resolution will require 30,000
markers. )
Mapping of the X chromosome is
progressing rapidl y, Schlessinger says,
and the goal is attainable. Another big
step will be taken in May of 1993 when
the Fourth X Chromosome Workshop
convenes in St. Louis, hosted by the

The ban ding of the X d,romosome,
showing its shorllllld long llnl1S.

Washington University team. From
around the world, laboratories interested
in the X chromosome wi II be repre
sented, and the flow of information will
accelerate again . •

- S.K.

So how is this new information
changing the way genetics is practiced?
You don't have to read scientific
joulllais to realize the impact the Human
Genome Project is having. More and
more frequently - witness the identifi
cation of candidate genes for cystic
fibrosis and mu scular dystrophy - the
news of such discoveries is reported in
the mainstream press. Improved maps
and more markers have helped decipher
part of the riddle of high-profile diseases
like di abetes and breast cancer. "This
gives us hope that more compJex
disorders, such as hypertension , manic
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Helen Donis-Keller, Ph.D., and Cindy Helms examine a map of chromosome 18.
depress ion and schizophrenia may be
mapable," Donis-Keller says enthu sia sti
caJJ y.
Access to genome data is improving,
which should spur more collaboration
and di scovery. UsuaJJ y when scientists
submit th eir mapping data and their
map s for publication, they do not make
the primary data (on which the conclu
sions are based) available to the scien
tific community. Donis-Keller and
others believe that access to primary
data is important. "People can ' t replicate
the experiments and they can ' t build on
the information with ju st a summary of
the data ," she says.
After the paper was submitted, all
data were transmitted electronically to
the Genome Data Base in Baltimore and
the CEPH in Paris. "Scientists can now
obtain the se data by electronic mail, or
they can have them shipped to them on
computer di ske tte s," Donis-Keller says.
Also , the ge nome map becomes a
" living document. " " Jfa scientist finds a
new marker, he or she now can deter
mine the place ment of that marker
within the map ," Don is-Keller adds.
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"The maps can be added to by anyone."
Access to information contained in
th e human genome is a trem endous ly
important issue for the public as well.
As a geneticist working to adva nce
knowledge of the meanin g of genes,
Donis-Keller is aware of the potential
misuse of the information her research
might make possible. She believes ge ne
mapp ing is going to change how we
view med icine. It will irreversibly alter
the doctor-patient relationship, she
think s. " We now can predict from birth
who is go ing to de velop di seases like
cystic fibrosis or adult-onset di abe tes or
hea rt di sease," Donis-Keller says.
"Know ing these genetic liabilities ahead
of time will change the practice of
medicine."
A teacher as well as a researcher ,
Doni s-Keller understands she ha s a dut y
to make it clear to first- year medical
students in her genetics class that they
mu st understand the fundamental s of
genetics, how they can be misu sed and
where e rrors come from. "Students must
understan d the power of the information
and how quickly it's going to change

during their period of clinical practice,"
she explains. " J think these practical
applications are an important part of the
mapping business, and maybe more
important than the map itself"
That duty to make the next generation
understand wh at her generation has
discovered manifests itself in unex
pected ways. Amid the ser iou sness of
her genetics lab lie s a colorful comic
book explainin g th e principles of
genetics. Doni s-Keller explains: " We're
beginning a project to de ve lop a video
game to teach genetics to children."
Perhaps that guided tour of the human
genome will be at a theater near you
sooner rather than later.

-
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Physicians Test
An Injectable
Drug That
Relieves Bone
Cancer's Pain
by Kleila Carlson

hen cancer " ' , /~
spreads to the ""/ ~
bone, the pain and '"
suffering associated with it can ~/,.
be enonnous. As the disease affects
cells deep in the body's skeletal
......-,
structure, it causes excruciatIng pain
"",/ ' '
<0
and weakened bones susceptible to fracture.
Patients with bone cancer metastasis also
' ~~, ~
face a shortened lifespan, though some survive
'~
" ' ~...
for several years and endure the tonnent of
their disease daily.

'"

"<,
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But researc he r:, are inves tigating an
Inj ecta ble treatment that may ma ke the
P(]ill 01 ' metastasized bone cance r easier
Lo bear. They ar" in vulved in a Na tional
Cancer lns Litute- "ponso red cl inic al study
of the dru g strolil il llll -RlJ that has be en
show n to relieve pain in 80 pe rcent of
people whose cancer has affected the
bone .

prescribed . " Hormonal therapy is very
easy to do and it ' · safe, so it i ~ the first
line of defense," he says. "But it only
provid es pain re iicf for 12 to 18 months ,
and a patient ' ,> average survival is 20 to
30 month s, so inev itably there will be
pain
When a patient becomes unrespon
siv e to hormonal treatment, two weeks

Once radiation levels are determined to be
appropriate, the patient is free to go.

"The pain of metasta ti c bone disease
can be unbearabl >," says Bahm an
mami , M .D., professor of radiol ogy in
the Radiation Oncology Center at
Ma llinckrodt In stitute of Radiolo!!y.
Emami, who directed the study at the
medic al school, adds. " Ov er a period of
tim e, the quality of li fe is affected and it
beco11l es mi s ' rable. That's why it' s
important we develop drugs to provide
comfort to pa ti ent ~ . '·
The mu Iticen ter stud y of strontium-89
is being conducted by the Radiation
Therapy Oncology Grou p (RTOG ), a
nationa l co llaborative research organiza
tion. Emami is the RTO G stud y's
principal in vestigator for Washington
University.
At prese nt, Emami says, therapic, to
curb th e pain of metastatic bone disease
are few. Radi ation therap y or horm onal
treatment, the mo st common form s of
therapy, succe:;sfully decrease pain in 60
to 70 percent of patie nts .
"Cancers like pro sta te and breast are
hormonally dependent , which means
there is H hormone specific to the cancer
and we ca n mani pulate it to relieve
symptoms ," says Emami. "Patients who
are hormonall y refractive do not respond
to hormone treatm ents. Between 30 and
40 pe rcent of patien ts fall into this non
responsive category."
Even with hormonal manipulation,
ex terna I beam rad iation is freq uentl y

18

of radiation treatments usuall y are
administered to ease pain . Emami says
about 40 percent of pati ent. th en become
pain free , another 40 perce nt get some
pain relief and 20 pe rcent receive no
benefit. Howeve r, Emami says radia tion
therapy is safe only whe n it is confin ed
to a locali/.ed area , an d it' s not useful in
prov id ing ge neralized pain relief.
An opti on for treating bone
metasta sis has been phospho rus in
radioactive form , or P-32_ Phosph orus
and calcium are two elements that occur
naturally in bon e metabo lism. When
pho sphorus is marked with a rad ioacti ve
iso tope and injected, it is absorbed by
proliferatin g normal cells, and ca ncer
cells at th e site are irradiated. Although
P-3 2 is effective at reducing pain, it

bone marrow as well as cance r ce lls. It
also ha s a sh ort hal f-life , which mea ns
th at it remains acti ve only for a sh ort
time and provi des onl y temporary pain
relief.
Emami says that strontium -89 wo rks
on the sa me principle as P-32, but, by
followin g a ditTerent pathwa y, res ults in
fewer and less "evere side effects.
Unlike P-32, st rontium-89 follows the
same biochemical pathways as calcium
into the bone where as a beta-emitter, it
irradiates cells only within the immedi
ate area of the bone cancer s ite. It also
benefits from a half-life of 50 .6 days,
more than three time.' that of P-32.
"The lon ger th e drug remains in the
body, the more e1lect it has on the tu
mor," says Emami. "Strontiull1-89 ha s
many benefits. Compared to extern al
bea m radiation , which requires a patient
to come in for treatme nt every day for
two wee ks, strontium-89 is given in a
singl e injection and should be effecti ve
for as lon g as one year." j\fter a patient
in the tri al rece ives an injectio n, he
remains in the clin ic for about an hour
while the lev el of radiation he is receiv
ing is carefully monitored. Once
radiation lev--:I' ; are determi ned to be
appropriate, the patient is free to go.
The first clinical study of strontium
89 as a trea tment for bone metastasi s
pain took place in J 974 and in vo lved 11
patients. ~; ;=:v eral sma ll er studies hav e
been done since that time, but the
c urrent study is tbe first large-scale
in vestigati on to evaluate its safety and
effecti veness.

"The most important result of this
treatment is improved quality of life."

causes serio us side effects including
anemia , hemorrh age and infection
because it is incorporated into the cells
of th e bon e marrow metabolically as
phosphoru s. As a result, it irrad ia tes

A study in Canada showed no
significant improvement in survival for
patients re ce Ivin g strontium-89 , but pain
re lief was impro ved and ne\v sites of
pain were fewer. Participa nts in that

study also repo rted an improved quality
Although in for mati on abo ut stron
me tastas ized li'o m thc prosta te. Slron
of li fe. eva luating item s suc h as their
tium- 89 as it relntes to patient s urviva l is
tium-89 also may have npplJcat ions wi th
own perceptions of pain and their
not yet ava il ab le from the latest
bone pai n associa\c.:d wi th breast. lung
activity le\' eh .
mult iccnter stud y, previous invc:,tiga
and th yro id e a ncer~. Ema mi says the
E mam i says the goal of the new work
tio ns have shown th at th e dru g reduces
drug h (l~ been used in a small number of
is to det ermi ne the max imuill safe dO~ e
th e level of prostate spec ifie antigen. or
cases \\lith (l ther types of hone me t
of stro ntium-8 9 . w hich until now has not
astas is. Ik l: mph asizes that it' s not the
PSA . in th e blood . PSA is a sen sitive
been estab lished, and to exa mine the
or igin of the cancer lhat is impOl1ant, but
ind ex for prostate cancer ac ti vity.
drug ' s analges ic efficacy. The 84
whe ther it has reached thc bonc . "'A ny
pa ti cnts who have
cancer has the
tak en part in the
potent iulto ge t
study had previous ly
into the bone, but
rece ived and been
th e preva lence is
differen t." he
unrespon sive to
horm one therapy.
says .
"We evalu ated th e
" 1 ,1111 hoping
toxici ty and efficacy
thM slro ntJ um- lN
offou r di ffe rent
WIl l provide
do ses of the dru g,"
comp lete pain
reli ef in 80
says E mami. "The
fina l data is being
percen t o f patients
ana lyzed now, and
and for a longe r
th e results are ve ry
durat ion than
pos itive , Jndicating
current therapl\::s.
th at stron tium- 89 is
We know radw 
very effec tive fo r
tJon IS sa fe when
bone pain."
used lfl locallzed
a 1"1::<15. hu t J f 1 du J
Carlos Pcre~~.
M D , director or the
hon e:: sean and see
fiv c difTcrcnl
Radi ati on Oncology
areas In th e b,)!1e
Ce nter. fee ls that
.~
that
arc (ca ncer)
preliminary results
iJa/lM ~~"nJ,
positive. I ca n
wi th st ron tium- 89
give radi ation
are " encouraging,"
and fur th er eva lua
on ly to the arl: a~'
that are most
tion may more
precise lye:-;ta blish
painful. With
its usefulness in
stro nl ium -89, \\ C
relieving pain
can <lI'kc t the
whole spectrulll of
caused by bone
metastasis. Once
the ske lcto n.
"Th e most
potential complica
important resu ll of
tions with the drug
thi s treatme nt is
have bee n uncov
im prov ed qua l i ty
ered and sc ientists
Bflhll/ill1 EII/tlmi, AI. D., explores 'he potential of.w/,o/lt;III1/ -89 {IS a meallS for
of lI fe." Emam i
are co nfident the
a/lel'iatillg the illtellse puin of ctll/cer Illal 1111.... m etaslu ....hed 10 Ihe bOlle.
conti nues . " Pa rl of
drug is safe, Emami
our work in
says resea rchers will
managing ac ute cancer pat ient.;; is
" At thIS time. we don't know how
eva luate it as an adjun ct to hormonal
su rvival, but th ere arc s ituatio ns in
stro ntium-89 IS able to reduce rSA
therapy. A prot oco l ex amining loca lized
leve ls," Emami says. But the impli cation
wh ic h there IS no cure . In those situa
ex terna l radiatlOn therapy ve rsu s
stro ntium-R9, after failure of horm ona l
is th a t thL' drug may Cel Lise tUlllor
tion s. it is ou r respons ibili ty to see tll a t
red ucti on bcsides its analges ic effect.
pat ients lIve a com lol1a hl e a nd acti ve
the rapy, wi ll also be conducted by th e
In add it ion to alle viating pain
lire for as many days . weeks or mo nth s
RTOG. wl th participation by Was hing
associa ted wi th bone ca nce r that
as th ey ha ve lett."
ton University.
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Experiences As A Study Participant

M

y urge is to resist research fellow Jason Hanson,

M.D., as he leads me through the protocol.

On e of his hands is on my chin and one is on the
back of my neck, smoothly turning my head left,
then right, in time to a pace set by a computer
generated tone.
The instructions to relax my neck loose," I'm told -

"just keep it

are almost impossible to follow.

Allowing someone else to move my head for me is
agonizingly passive, like letting another person ex
plain my opinions while I remain silent. The need to
exert control is elemental, a reflex.
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In fact, wh at Hanson and I are
evaluatin g in me is on e of the more
robust hum an reflexes, a criti cal
componen t of balance ca ll ed the
vestib ulo-ocu la r reflex, or VOR. I've
agreed to parti cipate as a normal
volunteer in a rese arch study called
the "head-sh ake proj ect." That's
what has put me in th is set of
unusu al circumsta nces. None of it is
unpleasan t, b ut the tota l effect is
foreign; th e overwh elmi ng feeling is
that anything m ight happen nex t.

In hi s medical school laboratory. Joe l
A. Goebel. M.D. , ad dresses tb e issu es of

··Twice as milny ototoxic p a ti e nt ~
surrer da milged ba lance as damaged
hear ing.·' Goebel says. ··A ne w \vay o r
assess ing the damage 111ay allow us to
stop the treatm ent from killi ng so man y
cells." If Goebel CUll find the th res hold
at which damage to cells affects bal rlO ce
and can mea sure it acc urately. h(; will be
ab le to ad\i se other ph ys icians when
irreparable dam age is being don e to the
balance system. The device must be
portabl e bec au ~c critically ill pati ent s
can' t cO llle to th e vest ibul ar lab that
Goebel direct..
To l11easure potential dam agc to th e
ear's sensi ti ve cell s, Goebel uses the
VOR, a primitive re ll cx that probably
evol ved as a surv ival mechani sm to
allow thc head to mo ve clTat ical ly while

keeping an im age steady on the ret ina .
Such a rencx \Vou lt! he import ant v.,h ih.:
ch asing a game animal over w ugh
terrain, as our early ancestors must ha v ~
done .

To witn ess the VOR at w(\rk , extend
a fin ger at arm 's length and shake your
head baek and furth whil e watc bing the
stati on ary fin gertip. The image silou lt!
he perfectly mainta ined without blUITing
by a heal thy VOR . In C Olllra ~t, holding
yo ur hea n still while wigg li ng th:ll li nger
back and forth and trying 10 foll ow it
with eye movement alone shoul d
demon slrate th e cl'kct ive nes<; orlhe
I t' Ilex.
When Ih e ce lls in the car nre damaged
or ki lied by ototoxic drug:" th eir death
shows up in reduced performanc.; o f the
VOR. Quantify the
decrease ill the VOR :mcl
you ca n measure the e ffec t
()f olotoxic ity {)11 balanc c.
accordll1g tu G u ~be l.

balance. He cxplores abnorm alities in
the vestibular system that is responsible
for an ind ividua l' s sense of balance. He
resea rches the aging o r the
system and the subsequent
increase in dependence on
visio n as a mean s of
maintaining balance at a
tim e of life when vision
also is failing.
In a third exp lorati on,
Goebel, assistant professor
of otolaryngology. and
post-doctoral fellow
Hanson are conducting a
study with direct clini l . ~ l
appl ications. The so-called
head-shake project aims to
create an effective,
po rtable device for
measuring the vestibu lo
ocular reflex at the bedside
of critically ill patients
undergoing chemotherapy
or treatment with powerful
antibiotics.
There is need fo r such a
device because, Goebe l
explains, " many of these
powerful drugs are
ototoxic - toxic to celiain
cells in the ear." Among
the susceptible ce ll s are
those dedicated to balance
and hearing. As a resu lt,
critically ill patients who
und ergo the most powerfu I
thera py freq uently emerge
from their treatmen t with
Jason Hanson, M.D., guides 'he hem/lllol'emellT of,he slIbject. With
damaged balance and
the shield lo wered, the ((Isk is to fix (III illlllgill(lIY, statifJIulIJ' I'i.m al
hearing.
target ",hile the head mOl'es.

To add to the
strangeness of my
si t uation, I'm w earing
the "h elmet of doom ," a
con traption that m ounts
on an adjus table
headba nd and drops a
black, featureless shield
a fe w inch es in front of
my eyes. In it, I m ust
resemb le Darth Vader
minus th e voice and the
cl oak. Th e idea, I' m to ld,
is to iso la te t he vestib u
lar input from the visual
input. M y eye move
ments are driven by the
ves tibular organs in my
ears.
M ounted on the
helm et's headba nd is a
vel ocity rate sensor th at
feeds informa ti on to th e
comp ute r conce rn ing
the speed at w hich my
head is m oving . Stuck to
th e temples beside eac h
of my eyes are elec
trodes designed to pick
up m inute cha ng es in
voltage in dicati ng eye
movem ent. " The eye is a
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Joel A. Goebel, M.D., (rear) studies the human vestibular 5ystem. Assisting him is laboratory supervisor Doug Fishel.

battery, but without acid" Goebel
explains to me. "The retina carries a
negative charge compared to the
front of the eye, so when the eye
rotates, there's a discernible change
in current."
My instructions are to imagine a
spot of light in space beyond the
shield and keep my eyes fixed on it
as my head moves . By comparing
the movement of my eyes to the
movement of my head, the research
ers gauge the strength of my VOR. If
my reflex were perfect, when Han son
moved my head to the left one unit
of measure, my eyes would move to
the right one unit.
When I have a target to focus on
- the condition the researchers call
the visual ves tibulo-ocul ar reflex, or
WOR - I can come pretty close to
the ideal of one over one. (The
computer's sophisticated software
makes adjustments for fluctuations in
the speed with which Hanson moves
my head.) But without the visual
input, in a purely vestibular environ
ment, if I do 70 percent, the re
searchers tell me I'm doing well .
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Despite all attempts by Goebel,
Hanson and laboratory supervisor
Doug Fishel to avoid qualitative
words like "good" or "excellent,"
try my best to track the imaginary
spot accurately, to relax my neck. I'm
participating because I want to do
well.
I want to know how I compare.
How are my reflexes holding up? If
I'm better than average - and can
get them to tell me so - I can feel
good about myself, set back the
clock. In the process, I get to learn
about my guidance system, a fasci
natingly complex operation that gets
almost none of my attention.
Unfortunately for me and my
mindset, the VOR is a true reflex; I
can't increase my performance by
try ing, Goebel says. In fa ct, distrac
tion from the task brings what he
calls the "ga in" - the movement of
the eyes over the movement of the
head - closer to the optimum.
Several problem s confron t the
researchers in their attempt to perfect
their device. In daily Ii fe, the speed of

head movements is often high. A gla nce
at the curb and then back into th e lin e of
travel is a quick motion; the impact of a
tackle on the football field is a hi gh
speed jarring. Tho se high frequencies
are impossibl e to reproduce by hand ,
and the headgear that record s the speed
of the movements slews around at even
moderately high speeds. That has made
th e replication of real-world head speeds
difficult.
Fortunately, however, lo wer frequen
cies are where damage to the vestib ular
cells of the ear appear first, Goebel says.
" W e hope to be ab le to catch th e damage
at the low end, before it gets into the
troublesome range ," he says . But there
also is difficulty in mainta inin g con
stancy of motion when speeds are very
slow. To help with the problem, the
recording computer also serves as a
metronome, and Hanson has practiced
his movements,
Because the researchers are looking
for the very best performance tbey can
ge t, they test three ways of imparting
movement to the patient's bead, Each
subjec t has his head moved by Hanson,
ha s the sw ive l chair in whic h he's seated

mo ved back and fOl1h by Hanson and
finall y moves hi s own head in time to
the beat. The res ulting numbers 
analyzed by computer algorithm to
remove arti facts - are compared to
in sure that all three methods are reliabl e.
Veri fication of results from the
porta bl e unit is provided by the lab 's
high er technology equipment. All
participants in the study first have th eir
VOR and VVOR assessed in a com
puter-controlled rotary chair that imp arts
preci se movemen t. The chair is capablc
of preci se ly reproducing frequenci es
rangin g from one direction change every
four second s to four direction c hanges
every seco nd . Tests in the chair are
perfonned with eyes open and a bright
target to foc lls on, in the dark whil e
imagining a focus point, and with the
visor in place.
T hese tests serve as a baselm e for
assess ing the accuracy of the portab le
me as uring system that will soon employ
a laptop computer and a portabl e sc reen
to provide patients with points of li ght
on whi c h to focus. The portab le system
should also be affordable for in stituti ons
th at can't mana ge the $ 1OO ,OOO-plus
reqUIred to in stall a rotary chair. Th e n
small er hospitals and clinics w ill be abl e

to e valu ate ototoxic damage to balance,
Goebel hopes.
Some of the data for the study I've
already provided. Baseline tests in
volved a ride in a rotary chair. Like a
carnival ride gone to graduate
school, the chair sits inside a circular
screen on which spots of light or
contrasting stripes of black and white
are projected to capture my visual
attention.
The chair moves in carefully
controlled arcs at up to 300 degrees
per second. With images whirling
past my eyes or blackness surround
ing me, I quickly lose my orientation
and can't tell where I am in relation
to the door by which I entered . Still,
the sense of being conformed to the
chair and presented with visual tasks
is not one of helplessness, but of
precision. Astronauts and fighter
pilots sit in chairs like this, taki ng
measure of their abilities.
While my visual attention is
focused on the object - real or
imagined - the researchers ask me
to list women's names alphabetically.
Instead of "Ann," "Betty" and
" Chris, " I choose "Athena,"

I" order to assess tI patiellt 's VOR at
bedside, the portable IIl1il IIses {/ slllilll.
curved screen 111 011 II tetl Oil a Iripod io
generate the visual target.
"Beatrice" and "Calliope." I get stuck
on "E" and end up going with
"Ethel."
I wish they'd quit distracting me
so that I could concentrate on doing
a good job of focusing my eyes. But
of course, the scientists want to test
my reflexes, not my effort.
When my part of the study is over
and the data have been anal yzed , it
turns out that my WOR is close to
what it should be; I overcorrect only
a little so that my eyes move slightly
more than they must to correct for
my head movement at a ratio of
about 1. 05 to 1.0. W ithout visual
input, my vesti bu lar organs correct
at a rate of about .7 to 1.0. Again,
well within what is to be expected.
And on the portable equipment, I
matched the results from the rotary
chair.
I've contributed a little something,
maybe helped out in the develop
ment of a system that will benefit
seriously ill patients . And I've still got
my reflexes; I' m still as sharp as ever.
As I leave the lab, Goebel thanks me
for my effort and pays me the com
pliment: " Yo u gave good data." •

A compuler-gellemteti.jield /rom the rotllry chair protocol shows 'he precise
lIIovemel1f of the chair (white IVlII'e) lit a j i'equell cy of. 5 " e ,.t~. The scaffered (lalli,
collected wi,II 'he lights off, represellt the s/lbject's ability to keep his eyes fixed Oil
all imagillal)' "is/wl turget.
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e pecial Te e lei S

h \' /'"iN oria Akins
ed ic al stude nt s ()rl'
supposed 10 be
bright, ta le llll:d and
scl f-!l1oti vat eu. We arc a lso
criti ca l, skepti ca l ~ l n d o ver
whe lmed by thc en orm ity o f
o ur tas k - t o become phy ' i
ci ans in io ur years. This
combi nat ion o j" facto rs
makes ed ue:lti ng Ullctllfs-to 
be a da unting ,'halle nge, par
ti cularl y during the fi r'st fW O
ycars of medica l se it ,)o lth at
co n ~ist pri m arily of class
roo m lea rning I lo wc\'er,
l11<1ny toc ul ty mem bers at
\~las hll1 g 1on
ni\'crs ity bri ng
p ci al tal e nt s and ucv()tio n
to the task .
O ur great k ac hers ea rn
our g ra titude and respecl.
More tang ibl y, \ 'e express
our apprec iation through
teaching a waru:. An nua ll y
s in ' e 19X(), s tudents have
c hos n a Pro [essm (l f tht'
Ycar fro m among full pro
fes, on. ,md a Lcct llrer o f the
Year rOll) among atha fa c
ulty for spe -ia l rec ogni tion.
What sets the r c ip icnts o f
h 'se awanJ apart'!
e le l 11 Conroy. Ph.D..
~o u U;C l11 aste r oC g ro s~
anatom y, vl' as na ill ed Pro fes
sor or t h~ Y ca r for 199 1-92..
and his course i~ cons iste ntly
nam ed Course of the Ycar by
tlrst-year med ica l ' tudents .
Como, and h IS wi re, Jane
P hill ips-C lnroy , Ph D.. both
anthro pologi :-.l, . rnovl:d to
W,I- hillgton IJni\ t!rsity rrom
Bro wn in 1983 . They ori g i-
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nall y visited ~' t. Lo ui s to ad
vise th e chairman of the e
partment of An ato my and
Ne urobiol ogy on th e fl:as i
bility of lur ing anth ro po lo
gi sts to tcach gross anato my.
After express ing tileir confi 
dence that anthr opologi sts
wo uld gladly j o in the Was h
ingto n Unive rsity l~l CL! l ty .
the y co uld n' t rc ~ i s t th e forth
coming j ob o ffe rs and
mov\': d to Sl. Loui s. In 1988.
Conroy a:-.s uIned the le ade r
ship of gross anatomy f r l )IT)
retirin g course mastcr Roy
Pet ~rs o n.
T he course ha<; "c hanged
with th e tim's," C mroy re
po rt s, w ith a redu ction in
cl a::;s ho urs and more clinica l
lectures than be fore. Conroy
teach es about ei ght lectures
during the cou rse and spends
co unt less hO llrs in tht: gross
anato my lab. goi ng from
ta ble to tab le to ouidl: d i % ~c 1ion and in struct ·tudents . In
ad d itio n, he att nels viltua lly
evt!ry lecture g iven in hi s
co urse. as do all of the core
fac ulty in gross ana tomy.
For ~[u d e n t s, t his practic e is
proof of the facu lty's interes t
and ded ica ti on.
Conroy u ~ e ~ the Soc ratic
ml:!th(ld, calling on stude nts
to an swe r question s in c lass.
Although students initi ally
may be in timidated by thi s
praces:. Conroy' s :1 bility to
make them fee l com fo rtable
and rhin k throu gh a probkm
a llow s them to rl: lax and en -

jo y the cxpe ri l: nce of talking
abo ut anatomy.
Mo rton Smi th, M .r, who
teac hes o phthalmol ogy to
so ph omore medical students
and was vutt! d Professor 0 f
th e Ycar fo r 199 1-92, also
use s the Socra tic method.
Hi s enthu s iasm for th e mate
ri al is infecti o us, and st u
de nts look fo rward to the
live li n ' S5 of hi s lec tures. Af
ter med ica l schoo l in his na
tive 'Vjaryland, Smi th train ed
at Washin gton Un iversit y in
op hth a lm o logy and path o l
ogy. with one year spent in
Washi ng ton, D.C, studyin g
ophth a lm o log ic pathology
and one year as chi ef resi
dent in ophtha lm ology . He
jo in ed the faculty in 1966
with a jo int appoin tment in
patho logy and oph thalm ol
og, . At that tim c, he was
placed in charge o f teac hing
op hth almol ogy to medi c,ti
stude nts.
T we nty-six years late r,
Sm ith is still teachin g stu
dents abou t the eye. T he fo r
ma t of th e soph omore
lec tures, whi ch are part of
th e prcparuti o ll fo r cli nical
med icine CO Ufse, has
changed over th e years in
res pon:,e to st udent [eed
back. Hovvever, the obj ec
ti ves in thi s lecture series are
straightforward: st udents
shou ld learn to recogni ze
ocu lar man ifes tations of sys
temi c d iseases and comm on
eye pa tho logy as well as th e

use of the ophth a lm oscope.
Smith g ives eve ry lectu l'e
and has for the las t 10 yea rs.
In thi s way , he ass ures th at
there is no red undancy and
ma intains his ow n high stan
dards.
system or strictl y cI i
daetic le ctures turn s bright
peopl e into du ll people,"
says Ed 1cksk 'y, PhD,
who was named Le cturer of
the Year fo r th e second tim e
in a row last year by the
fresh man c lass. A ltho ugh he
humbl y attrib utes hi s pop u
larity to the s ubj ect matter he
teaches in ce ll bio lo gy, stu
de nts know th at 13 hours o f
me mbra ne tran sport and ex
c itability co uld be a ni ght
mare if McCle skey weren' t
helpin g them :.ort it out fo r
th emselve '. In hi s commit
ment to a iding inde pendent
thou gbt and interac ti ve
learning, th is fall McC leskey
radica lly chan ged hi s suc
cessful lec ture fo rmat to a
more prob lem-based ap
proach and add ed Se vera I
clinica l lectures.
McC leskey rece ived hi s
Ph.D. in physiology and bi o
ph ys ics fro m th e Uni ve rsity
of Wa shington in 1983 . A f
te r po ·t-d octo ra l wo rk at
Yal e, he acce pted a fa culty
posi ti o n at Was hin gton Uni
vers ity in January 1987, a nd
was recently prom oted to
associ<l te professo r o f ph ysi 
ology . Accord ing to
McCl eskey , o ne of the ad

Teaching ((ward '11;lIners .Morloll Smith. M.D.; Edw;"

va ntages of being at a re
sea rch insti tu tion \~ ilh 800
full-l ime fac ul lv and 500 stu
dents is the opportunity for
sm all-grou r teac hi ng and
lea rnin g. lk has h igh praise
for th e elective series offered
to fres hmen medica l stu
dents, desc ribi ng it as one of
the "creat ive out lets" in the
first-year curric ulum. lie
says he is extreme ly im
pres sed by th e work the stu
dents have done. C lea rl y. the
fee lin g j ~ mutual.
Th e r atho logy of lhe ncr
vou ~ system becomes a
brigh t spot in th e second
yea r curriculu m thro ugh the
in spired e ffort s of Ke vin
Roth. M.D., Ph.D .. who was
named Lecturer 0 f the Year
by las t year' s class. Ro th
took over th e ne uropath ol
gy section o f the patho logy
co urse when he became a
fac ulty member in 1989 . He
enjoys the chal lenge of

.~/cCleske.r.

teac hing med ical students
and takes an interac tive ap
proach, rec ogniz ing that
cli nical releva nce is es pe 
ci all y appreci ated by the stu
dents as they approach their
third-yea r clerks hips. Rot h
emphas izes the importance
of learning th e materia l. His
obvious enthu ~ i asm for
teaching and the ~ ubJ e cl mat
ter makes the exrerience e n
j oyable.
Roth graduukd w ith an
Iv1.D. and a Ph D. in neu ro
science from Sta n ford in
1985 and camc to Barncs for
his residency in anJtom ic
pathology, follow ed by a
fellowsh ip in neu ropathol
ogy. He accepted a facul ty
pos it ion at Wa~ h i n gtoll Uni
versity in 1989. Cli nica l
work takes up on e-third of
hi s lime , and another third is
de voted to resenrc h on the
regulatI on of neuroper tidc
ge ne expression . The re-

Ph.D.; Kel1ill Rut", M.D., PII.D.; {Iud Glellll Co,,/'oy, Ph.D.

Inili nder is spent tCilc hing
medieil l students and res i
dents. Roth " Ii ke(s) to teach
people who want to leam."
so he also meet s wit h unde r
grad ua te psy chology stu
dents a coupl e of times a
lear to show them gross
neuropathological spec ime ns
" for as long as th ey'll stick
arou nd. "
Besid es gi ving three lec
tures and lead ing many labo
ratory smail-group sess ions
in the pat hology course,
Rot h is fam ili ar to stud l:n ts
from au topsy confere nces on
Thu rsda y morni ngs , where it
is hard to tell hi m from the
residents. Stuuents seein g
Ro th in ten nis shoes <mel a
baseb a II cap are encouraged
to believe him wh en he says,
'T rn just like you, just fur
ther a long."
any oth er specia l teach
ers have in sp ired us wit h the
orga ni 7ation of ti1e ir

though ts, then ent husi asm
for the ir subject matter and
thei r ability to con vey it to
us effic icntly :m d mea ning
full y.lor all ofthcl1l. th e
ti mc -cons uming job they du
to pass on wh at they know
$e e m ~ to he an cnjoyab k
ex perience that challen ges
anu fulfil ls them. When we
see Ed McC leskey roller
skati ng 10 \,vork or Ke vin
Roth playing air guita r in our
cl a<;~ show, when we hea r
Mort Sm ith talki ng about the
sports car he'd li ke to dri ve
or G len n Conroy remini sc ing
about h i~ ol d Harky 
Davi dson, we rec ognize
people who love li fe and
love what they do.
Ed. Note-: Victoria Akins
is a third-year m edica l stu
dent. married. with tll'O chil
dren.
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Silhoue te
by Marion Hunt
or his 50th reunion in
1992, C. Barber
M ueller, M .D . '42 ,
thought of a uniqu e g ift to
honor his teachers at the
School of Medicine. Now
Profe ssor Emeritus of Sur
gery at McMaster Univ ersity
in Ontario , he had long felt a
need to express his gra tin.lde
to the sc hool th at had given
him a full four-year schola r
sl1ip in 1937.

C. Barber Mueller, M.D.

26

While he had been a gen 
erous contributor over many
years, he sought a special
way to express his feelings
for the professors who had
provided him with a first
rate medical educatio n.
Thank s to his ge neros ity and
imagination , hi s gift stand s
in the atrium of the new
medical library : a history
display recounting the story
of thi s sc hool and people

wh o made major contribu 
tions to its development. On
nine sides of three trian gular
kiosks are pictured six of th e
professors who made such a
difference in Mu e ll e r' S edu
cation - as well as othe rs
from decades before and
s ince he graduated.
A mod es t brass plaque
co ntains his tribute to them:
"This display is dedicated to
those men and wom en of the
fac ulty who so enriched my
life as I passed by .... " Visit
ing alumni will certainly find
memorable teache rs from
their years here, many who
achieved nation a l and inter
nati onal prominence
among th em Carl and Gerty
Cori, Eva rts and Helen Gra
ham, George Bi shop, James
O'Leary, M ildred Trotter
a nd Ca rl Moore.
"The key person in my
medical educa tion was Philip
Shaffer, because he opened
the door," Mue ller says,
speak ing of th e distinguished
biochemist and dean w ho
made the fateful decision to
give him a full-tuition scho l
arship . In the fa ll of 1937 ,
Mueller's mot her had read
th a t the medical schoo l was
starting the Jackso n Johnson
Scholarship Prog ram. "This
was sti II the Depression, and
with m y family's limited re
so urces, it was almost cer
ta in that I was go ing to the
University of Illino is Medi
ca l School; in fact, [ never
considered anything e lse,"
he remembers.

However, with his
moth er's e ncoura gem en t,
young Mue ll er agreed to
v is it St. Louis. Shaffer inter
viewed him. " I was a bo y
stric tly out of the corn
fields," he recalls. No doubt
wh at impressed Shaffer was
the candidate 's sup erior aca
demic record both at
Blackburn College and the
Unive rsity of lllinois. Their
conversa tion lasted a ll of 15
minutes. " 1 sus pect Dr.
Sha ffer himself con stituted
the entire adm issio ns com
mittee for the Ja ckso n
Johnson Program," Mueller
says. Shaffer's ability to dis
cern aca demic qu ality was
superb; of eight Jackson
John son Scholars accepted
the first year, seven gradu
ate d in th e top 10 of their
class four years late r, among
them Barb er Mu e ll er.
Two weeks after his vis it,
a letter arr ived wi th the news
that he had wo n admission
and a four-year sc holarshi p,
along with a National Youth
Administration (NYA) job to
help with his li v ing ex 
penses. "The National Youth
Administra tio n was a New
Deal program to put young
peo ple into paying positions;
Washington Uni vers ity was
given a number of these to
distribute to s tudents," he
explains. For Mueller, the
tasKs he performed contrib
ute d di rect ly to his future
career; in addi tion , the job
paid eight dollars a wee k

through hi s fo ur years at the
School of Medicine .
The fi rst of his tasks was
rea ding nerve tracings and
preparing lantern slid es for
George Bishop and Jam es
O'Leary in th e Departm ent
of Neurology. The next yea r,
Mueller worked for Na than
Womack, a professor of sur
gery w hom he describes as
"a most unusual and Imagi 
native man. He put me to
work doing pancreatect
omi es in dogs to study a pro
posed diabetogenic hormon e.
This was my first bit of sur
gery." That experience led
him to choose surgery as his
majo r interest and eventua l
spec ialty cho ice. During
Mu ell er's seco nd and third
years , he worked on wound
heali ng studi es which led to
his first two pap ers, pub
li shed with Evarts Graham.
As a se nior medical stu
dent, he naturally so ught
Graham 's adv ice about a
surgical internship. "T told

"I

(HU~

plural pronoun, I think th e
decision was strictly his."
In the spring of 1943 ,
Muell er dec ided to accep t a
co mmi ssion in the United
States Navy and made an
ap pointment to te ll Gra ham
abo ut it. Grah am offered to
have his com mi ss ion de
fen'ed so that he could finish
surgica l training. The yo ung
intern said he'd return in a
few days with hi s decision.
" I knew that if I made up my
mind in front of Dr. Graham,
J'd make it up hi s way, and 1
didn't wa nt to do that. In the
end , I decided to leave."
Muell er se rv ed as a medi
ca l officer with the U.S. Ma
rines in the Pa cific Theater,
maki ng sure the wounded
got back to ships. He wos
himself wo und ed at Jwo
lima.
But hi s old ch ief had not
forgotten him. In 1945, Gra
ham wrote him, asking
whether he'd be interested in
a Rockefe ll er Fello wship .

first: of all. an rfill('ator.

him I wanted to do thi s ei
ther at Yale, Ch icago, or
here in St. Loui s. I went
back in a coupl e of weeks,
not knowing that th e chai r
men at these other depart
ments were hi s close friend s,
and Graham sa id, 'We've
decided th at you'll stay
here. ' Though he used the

Mu ell er re plied that as soon
as the war wa s over, he'd
accep t. At his military dis
charge in 1946 , they met in
St. Loui s; Graham asked him
with character istic direct
ness: "What would you like
to do')" Mueller answe red
th at he ' d like to study bi o
ch em istry at Harvard, and

TIt(1 It islO1J' kiosks ill lit e
M edical Library alld
BiocOlll fllllllicaliolls Cell1er.

with Graham's help he did
so in the laboratory of Baird
Hastin gs. "It was a spectac u
lar yea r," he reca ll s. " That
time opened up mineral and
g lucose metab oli sm, mem
brane dynami cs and turtle
heaI1s." Graham intervened
again in 1949, offering him
the first positi on as a Markl e
Schol ar. Under this new
five-year program, he could
move sm oothly fro m labora 
tory an d clinical trainin g to a
faculty position.
In 1956, Mueller left hi s
position as an assis tant pro
fessor of s urgery at Wash
in gton Uni vers ity to beco me
the first full-time head of
surgery at the State Uni ver
sity of New York , Syracuse.
Muell er remembers: "Expe
riences at Wa shin gto n Uni
versity and Barn es Hospital
certa inl y colored my ap
proach to my new rol e.
Evarts Graham had stru c
tured the program for student
education, progressive resi
de nt respon sib ility and clini
cal excellence. I in trod uc ed

many of these id eas into the
surgical scene at Syracuse."
Though justly proud of his
specia lty. Mue ller says of his
career: "I am, first of all, an
educator."
Ele ven years later, he ac
cep ted an invitation to hea d
the new Departm ent of Sur
gery at McMaster University
in Hamilton , Ontario. Here,
too, he pu t his co nvictions
about th e best possible surgi
cal training to work. "At
Mc Master, as at Syracuse,
there was no resid ency pro
gram whe n I arrived. " Build
in g excel lenc e from the
ground up had become his
edu cational spec ialty.
An emeritus professor
sin ce 198 3. Mueller contin
ues to wo rk and trav el at a
remarkable pace, se rving on
committees of spec ial inter
es t at McMaster that deal
with educati on and med ical
eth ic s. In 1988, students
there honored him with the
Students' Teaching Exce l
len ce Awa rd. Despite hi s
long resid ence in Canada,
Mueller nev er has give n up
hi s midwestern roots; he
serves as a tru stee of
Blackburn College and has
endowed (dlO\>,s hips in th e
humaniti es at the University
of Illino is. Washington Uni
ve rs ity honored him with a
Found ers Day Award in
1977 an d an AIumni
Achie vement Awa rd in
1987. " All these years later,
my deare ~ t friends are in St.
Louis," he says si mply . "I've
bee n trying to figure out how
to show my gratitude to the
med ica l sc hool for the la st
50 years."
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Alumni Be ort
COllllnitment And Paletieil.atioll
Do IOI-ed Witll A"'81..tS
gala dinner at the Ritz-Carlton Hotel was the settin g
on riday_ September 11. when the School of Medi cine
presented tile three Second Centur Awards for 1992.
M sde of the most prec ious materia ls - gold si Iver and
marble - the award elebrate the advent o f the second h un
dred years of excellence in resea rch, teach ing and patient care
at the medical schoo l. It is presented in recog
nit ion of indiv iduals vhose long-term commit
mcnt, dedication and generollS participation
havc made 11 great difference, enabl ing the
chao! o f Medicine to enter its second cen tury
w ith unparall eled ' treng th and confidence.
Says William A. Peck. M,D ., vice ~hanc 1
lor for medical affairs and dean of the Sch 01
of Medic ine, 'With this award, we how ur
appreciation to those people who have pro
vided the means, tbe inspiration the in tellect
and the spirit to drive our important work for
w,u·d."'
Tlus year, Seconu Century Award!': were
pre, en ted to Oliver H. Lowry, M.D.. Ph.D .; P,
Roy Vagelos, M.D., and Spencer T . Olin .
L wry, Distinguished Professor Emeritu' o f
molecular biology and pharmacology, has for
45 years devoted Ius o Lltstand ing scientific,
educational and administrati ve ab ilities to the
medi al schoo!. He came to the school in J 947
as profe sor and head of the Department of
Pharmac logy and led the department thro ugh
a period of tremendoll growth . From 195 5
through 1958 , he served as dean of the Schoo l
of Medic ine. He retired as department head in
1976 and became professor emeritus in 1979, but maintains a
highly ac ti ve researcharecr.
An intemationally renown d hi stoch mi st whose tech
niques and approaches have had profo und effects on science
Lowry has widely inOucnced resear I in the ar eas o f nelU'obi 
ology, neurochemistry and bi ochem i try. He was e lect d to the
American Academy of Arts and Sc iences in 195 7 and to the
_ ational Academy of Sc iences in 1964. T he annual O liver H .
Lowry Lectureship was e~tab li shcd 111 19 78, and the Oliver H .
Lowry Prize for Exce llence in Pharmacology was created in
1980. He was awarded an honorary Doctor o f Science degree
from Washington University in 1981.
P. Roy Vagelos, M.D., is a scien ti t and physician with a
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gi ft for innovation and corporate leader hip . President and
chief executi e officer of Merc k & Company, Inc. , since t 985
and chairma n of the board of dircctors since 1986, Vagelos is
widely recognized as the leader who changed tile focus of drug
development fro m simply treating symptoms to finding ways
(0 block the processes that actua lly C3lL'iC medical prob lems.
He joined Merck in 19 75 as president of its
re eareh division a fter nine years a, chal nnall
of tbe Department of Biological C hem i try at
Washington University Sebo 1 of Med icine.
At the medica l school h put together an out
standing research team and gained renown as
a biochemical researcher and as a person who
rec gnized talent, challenging his associates
and his staff to reac h thei r fu ll poten tials . He
also founded the university'S di visio n o f biol
Ogy and biomedical sciences and di rected the
division from 1973 through 1975. The divi 
sion continues as one of the maj or bridges
between the medical and hilltop campuses.
Vagel os received the nzyme C hem istry
Award of the American Chem ical Soci ety in
1967. He was named 1992 Chief Executi ve of
the Year by e hie/Execll ti ve Magazille, and he
has been profiled in many of the nation ' s ma
j or busin css publications, On August 13,
1992 , he received the coveted E ll is 1 land
Medal f Honor. He is a member of the Na
tiona l Academy 0 f Sciences and the Am rican
Academy of Arts and Sciences. He holds an
earned Doctor f Medici ne degree from Co
lumb ia Un i er ' ity College of Physici ans and
Surgeons and has been awarded honorary doc torates fro m
seven universities. including a Doctor of Science degree from
Washington Universi ty presented in 1980.
Spencer T. Olin, now re tired. has been a business and com
munity leader in St. Lo uis for many year'. He has been a ma
j or benefactor to Wa ' hington Univ rsi ty and the Schoo l of
Med icine
Si nce b ginning his busine s career at Westem Cartridge
Company in 1921, Olin has been dedicated to commun ity im
provement. He became a mem ber of the board of trustees of
Washington Univer ity in 1957 and wa awarded an honorary
Doctor of Law degree in 1969. In 1975 , he received the liot
Society ' S Search Award.

Oliver H. Lowry. M.D.•
PII.D.
His generosity a11d th at o f
the Spencer T. and Ann W .
Ol in Foundation to the
School of Med icin e is evi
dent in its research, teaching
and clinical activi ties,
through gifts to departmental
work and research proj ects,
including support of the di vi
sion of biology and biom edi
cal sciences that provides the
Olin Fellowships fo r Medi
cal Scientists in training and
the annual Olin Symposium;
gifts for buil d i n g ~ . and
through th e establishment of
the Spencer T. O lin Profes
sorship in Psychiatry.
At the dinner ilttendcd by
more than 400 eminent
members of the medical
school community, William
A. Peck, M .D ., vicc chancel
lor for medical affairs and
dean of the School of M edi
cine, presen ted the awards.
Chancellor William H.
Danforth, M. D ., addressed
those gathered following a
toast by Lee M . Liberman,
chairman of the university's
Board of T rustees. Joel D.
Cooper, M.D. gave the key
note add res s describing his
work with sing le lung tran s
plants. Presenting a patient
who had benefited from the
revolutionary procedure,
Cooper exemplified the in
terplay between research and
patient care that is the hall
mark of the school.

The award, designed by
Heikk i Seppa of the School
of Fi ne Arts. si gnifi es the
school 's h i gh c~ t p urpose: the
healing of humanity. It is
fashioned from a flat trian
gular sheet of gold into a
strong form suggesting the
comers of the world from
which know ledge is gath
ered. That know ledge, re
fined and expanded by
dedicated teachers, research
ers and clinicia ns, is mani
fe sted as a pure sil ver fla me
in the center.
The firs t Se cond Century
Awards were p rese nted last
year, during the schoo l' s
centennial celebration, The
two recipi ent s were Robert J.
G laser, M. D ., and Harriet
Baur Spoehrer.
Glaser received his medi
cal degree from th e Harvard
M edical School and trained
in internal medicine at Bar
nes Hospital and Peter Bent
Brigham Hospital. TIc joined
the Washington U n iv e r~ ity
medical school faculty in
1949 and rose to the rank of
associate professor of medi
cine and associate dean. In
1957, he went to the Univer
sity of Colorado as vice

The aWl/rti/o Spencer T.
Olil/ wa.~ accepted by /tis
dlll/glller, MOlY Dell
Pritzlaff; (I member of the
Washington U"iversity
bounl of fmslees alld tile
medical school's NafiOllll1
COlllldl.

presi dent for medical affairs
an d dean of medicine and
later served in the same ca
pacity at Stanford Uni ver
sity.
Since 1970, G lase r has
been invol ved in medical
and scientific philanth ropy.
He was president and ch ief
executive officer of the Ka i
ser Famil y Foundation and
now is a trustee and director
for medica l sci ence o f the
Lucill e P. Markey C haritable
Trust.

a long-ti me vo lunte er at St.
Louis C hil dren 's Hospital.
T he rec ipien t of the 197 3 SI.
L ouis Glo be-Democrat
Wom an of Achievement
ward, Ha rri et Baur
poehrer was a supporter of
Ci vic organizati ons and pro
grams such as J unior
Achievement.
A gradu ate of Was hi ngton
ni versity, she was a life
member of the El iot Society .
Rece ntly, her genero us sup
port of the School oi' Med i-

P. Roy Vage/os, M.D. , receives his {lIvardfrom William A.
Peck, 1.,,1. D.

G laser is a member of the
American Academy of A rts
and Scienc es and the Insti
tute of Med icine of the Na
tional Academy of Sciences.
He has received many hon
orary degrees, including one
from Washington University,
and has serv,.~r! on the uni
versity'S board of trust<;c~
since 1979, where he chairs
the educational policy com
mi ltee . I-Ie also is chairman
of the medical schoo l' s N a
tio nal Counc il.
Harriet Baur Spoehrer's
unrivaled involvement in the
St. Louis community in
cluded her deep commitment
to the intellectual growth of
students at the medical
school and to the education
of youth in general. She en
dowed the Spoehrer Profes
sorship in Pediatrics and was

cine made it possibl e for re
searchers to lay the ground
work fo r innovative
programs, particularl y in the
ficl ds o f pharl11ilcol ogy and
the Human Genome Project.
Mrs . Spoehrer also was a
dedicated supporter of til e
med ic al school's ne w M edi
cal Library and Biomedical
Commun ications Center.
TIle presentation of the
Second Century Awards hilS
become a major event on the
School o f Medicine calendar.
"1l1is is one small way in
whi ch we arc able to acknowl
.:dge some of the generosity
tha t our :s upporters show to us,
and it is the bcginn ing of what
will become a long tradition,"
says Peck.
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John W. Records, M.D.
'36, has had a chair endowed
in his name in obstetrics and
gynecology at the University
of Oklahoma. The endow
ment wu. made po sible by a
gift from his . l)n, George J.
Records, and his family and
contributions from the fac 
ulty. with matching funds
provided by the State Board
of Regents for Higher Edu
cation.
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VerDe F. Goerger, M.D.
'40, ha attaint:d the age of
77 and describes himself a~ a
"computcr nut' who cares
for a sa lmon-crested cocka
too and a cockateel at his
home in Harlingen, TX. Re
tired for 10 years, he is fa 
ther to a son and a daughter,
grandfather to a /:,'Tand 'on
and a granddaughter.
J. Stewart Whitmore,
M.D. '49, has been ap
pointed adjllnct linieal pro 
fessor in the department of
radiation oncology at East
Carolina niversity School
o f Med icin in Greenv ill e,
NC. He and his wife of 43
years have lived in Washing
ton. _ C . ince his retirement
from private practice fi ve
year, ago.
GeraJd W. Cady, M.D.
'52, retired from practice in
May, 1992. In 1991. he re
ceived the Founding Father
Award from the San Diego
Chapter of the We tern Or
thopedic A. sociation.
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Roger J. C. Meyer, M.D.
'55, continues to serve as
clinical professor of pediat
rics and public health at the
University of Washi ngton.
He has been newly ap
pointed to direct the Acute
Illness Cli mc at Madigan
Army Medica l Center for
Health Speciali st. In addi
t ion, he works overseas oc
casiona lly as an Am1Y
Medical COil> ' reservist. Tn
that capacity. he recently
helped immunize 57.000
people against N meningi tis
as part of a State Department
campaign in Cameroon.
Meyer call the experience
"the most exciting and pro
ductive public health contri
bution," of his professional
Ide. because thousands in
that area die of the diseuse
each year without immuniza
tion.

"60s alld "70s
Philipp Ii:. Bornstein,
M .D. '67, serves as presiden t
of tbe medical staff at S1.
John's Hospital in Spring
fiel d, IL. He was named a
fe llow of the American P'y
chiatric Assoc iat ion in 199 I,
has erved on the editorial
board f thcAllna!s o(Clini
cal PsychiatlY si nce 1989
and was recently board certi
fied in geriatnc psychiatry.
He reports that he has trav
eled extensively in the Fa r
ast.
Wallace B. Mendelson,
M.D. '69, has been named
director of the ncw intcrde
pa11mental Center fo r the
Study of Sleep and Waking
al the State Univer ity of
New York . Thc center is
dedicated to clinical care and

Edward S. Hume, M.D.
'75. serves as chairn1an of
the Department of Psychiatry
at Community General Hos
pital in Syracu e. Y and
maintains a small private
practice in forensic psychia
try . Married to the fom1er
Sue Ferrara in 1986, he is
the father of one child,
Katie, age three.

research in sleep disorders.
Participating physician' in
clude specialists in sleep
medicine, internal medicine.
ncurologyand family prac
tice.
David W. Ortbals, M.D.
470. was recently appointed
associate: cOlUlcilor for the
State of Missouri by the
Southern Medical Assoda
tion.

•1
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hen reu l1 ion - goer~
/ gathered JI1 St.
Loui. in \I1ay 1992.
the alum ni and development
stn fT aga in asked (al1long
other thi ngs) for any advice
the alu mni migh t ol'G rto
cu rrent students as a r..::sult of
their long experiences.
Many of the responses
foll owed th rec hasic tlle111CS:
I ) Impe nJing ch~lI1ge: . in
medi cine and its practice
wil l test you . 2) Guard your
intt:grit/ jC<llously . 3) In
clinical practice, pu t patients
firs t. LIcre nrc a few o f the
more concise pieces of ad
vice for tnday's s1uuents.
arranged by the ir las~ or
origin. A CO 111 pI ' t packagl:
of all of the responses was
prepared by the A IlIT11ni and
Deve lopment starr and dis
tribu ted to med ica l slllde nts.
The :e lec ti ons here appear
mi nus attribution, tor the
protect ion of tile mlvice-g iv
er" .
I /

19:12
Don't go [or t he "gold."
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Take advantage of every
(pportun ity to 'n large your
know ledge o f metli clfil'
all phases .
I ' lew \\ ith cons iderable
regret the ('olllmercia lization
of American medicine. Dur
ing the 50 years since gradu
atim . there has bee n no
~ig l1 ilkant change in the
two-tiered syste m in whi ch
we pnlctiee - th e best med i
ca l cure in ' he \\lorld for
those who (;<111 afrord it. and
muc h Icss for those who
an' 1. I bcli ev ' in equa l ac
TSS to l'qua l quality of care
for all Americans and tl1 <11
medica l carc has no business
being a businl:ss if anyt hing,
rnedicim: has hee( me much
less oCan Idea listic profes
sion than it was 50 years
ago .

Gary L. Baker, M.D.
'77, F.A.C.S.. assistant pro~
fessol" of plastic surgery
practicing at Kansas Univer
sity Medical Center, has
been elected to the stanIS of
fellow in the American Col
lege of Surgeons. Baker is
the only Kansas C ity plastic
surgeon currently certi ned
by four separate American
Board of Medical Special
ties-sanctioned boards.

19-12
Strive to becomc the hest
phys ician you possib ly can
he. hut aJ~o pay great atten
tion to politics and pat1ici
pale 10 what~·\ t'r ex tent you
cun. hccall'>t' rolili~allrl'nds
an;, "lwplIlg ollr lives.

19-1
I ha\ e heen teal:hing
med ical ~llJ(Jents ~inct: I
graullated rrom Washington
U. t h,1\ e fLllJlld myselrre
pealedly quoting Dr. Ed
Re1l1ha rd \\' ho summarized
medical sc hool edlicatlOn by
adVIsing: "Listen tl) the pa
lien t Illng enuugh and hI.? will
[e ll )'llU what is wrong wllh
him . Listen I() minute~
longer and he will Idl you
what to do for it."

19;)~
Fighl as hard as YOli can
derend the medical
p rore~~ion's honor. integrity
and place in ~uciety .
10

Jeffrey P. Cicbon, M.D.
'79, has "reactivated" as a
clinical professor at the Uni
versity of Nevada Medical
School. He is involved in the
residency training program
in ol1hopcd ics. and hi s wire.
Vicki, is active in the Ameri
can Juni or League and with a
local medical auxi liary
chairing committees for
charitable events.
GlIr), L.

Baker, M.D.

Despite CLIITCnt pu blicity
and ~ol1cern for fiscal 111 at
tel's. our unrortunate lit igIOUS
clllnute and over-/cnlous
regu lators. medicine fCmains
a \Vontlert"ul career (or those
inteJ'estt'd ill science. people
and <.;en ice. Til11e~ anu CII"
eLll1lslal1l:es will change. hut
the cure 0[' a mcdical career
will remain . Accordlllgly: I)
pursue your goals of excel
lentT 2) :lVai l your-;cl r (If the
opp(lrtlln i tj~·s at Washington
U . 3) \..ccr your idealism .

........
,.)

Training rl.?ceived in
n.:dleal ~eh\lul is mor~ i m
portantthan olkn rea li zed .
Though medicine changes
' on~tllntly and muc h t,r early
I:ducation hccome.:. dated. it
rnl\ ilks a I"llundatioll for
later .

...·)
19
, 1Ask. "How can I make a
Ii rfe renee?"

LVl.?rything i~ relevant to
Ih e practice of Illetiil.?ine .

~

Pick the brains of c\ery
faculty mcmber YOI1 meet.
Learn whal ques ti on~ to a~k
and never lose your Cllrills
ily .

I !)fj2
Do your bc~t for the right
then rol l wtth the
punches .

rea~on.

!tfj7
Hang in there. It is n:al ly
worth the lime and elT0l1 to
succeed at a school li ke
\Va~hington University.

Don ' t put Lip with sexist
behav ioJ.

1977
YllU Hrt' privi1eg\.:d 10 ht'
going to lil t' fines l Illedica l
;choo l in the ClHlntry . "\Ie\er
l()rget the worti "p rivilege"
anti remembcr where you
and many or your c l a~sl11atcs
(lime from . Never lose the
youthl'lI l Ical and idea li sl1
that hrough t yo u to medica l
scho(ll.

Donald A. Opila, M.D.
'79, F.A.C.P .• has been
named Young Internist of
the Year by the American
Society of Internal Medicine.
The award has been given
annually since 1969 to rec
ognize outstanding contribu
tions to Ihe socia l and
economic environment or
internal medicine. Orila is a
clinical assistant professor of
mediCine at State Uni vers ity
of New York at Buffalo. As
the coordinator or the Pri
mary Cnre Trac k Residency
Training Progranl, Op il a de
velops and implemen ts the
curriculum of internal medi 
cine residents and medical
students. He organizes prob
lem-based discussion groups
and arranges mentorship
with primary care physi 
cians. Students often spend
their primary care rotation in
u rural or HMO setting rather
than the traditional hospital
or clinic . In 1991. Opila di 
rected :l demonstration
project funded by the New
York State Department of
ocial Services. The project
helped non-acute Medicaid
patients who seek care in
emergency roOI11S 10 see pri
mary care physicians in
stead . Currently, Opila is
rresident of the Buffalo
Academy of medicine. a
member of the New York
Slate Society of Medicine
board of directors. immedi 
ate past president of the
Western New York Society
f Internal Medicine and is a
fellow in the American Col
lege of Physicians.

31

Dennis P. DeVito, M.D.
'80, bas joined Childrcn' s
Orthopaedics of Atl anta,
P.C , a private medical prac
tice devoted to the orthope
di care of infants, children
and adolescents and arR li
ated with Scottish Rite
Chi ldren '. Medi cal Center.
DeV ito and hi ' wile, iki .
res ide in Alpharetta. GA
with th eir four childrc n.

promoter elements and
D A-binding proteins re
sponsible for tran scriptional
act ivation. Wilson is one of
five Pfi zer Scholars named
for the year. The award of
fers financial support of
$65,000 annually for two
years.
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Pfizer Scholar DUI,jd B. Wi/
M.D.

David B. Wilson, Ph.D.,
M.D. '86. an instructor in
pediatrics in the Division of
Hematology-Oncology at
liar ard Med ica l School and
Bo~to n C hild ren's Hosp ital,
ha been named a 1992
Plizer Sc hol ar. Wilso n" rc
search interest is vascular
biology. As a Plizer Scholar,
he wi ll geek to understand
thc transcripti ona l regu lati on
systc m of gene. expressed in
endot heli al c lis. He hopes
to identify and characterize
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John S. Pratt, FRS in
surgery, was an in vited
speaker on breas t cancer at
the 5th Annual Sym posi um
on Medical alpractice
sponsored by the Law Jour
nal Se minars Press at the
Waldorf Asto ria in cw
York, June 8 and 9, 1992.
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Harper S. Jackson, HA
'79, senior vice presi den t at
th e M thod ist Hosp ital in
Houston, was recently ad
va nced to fellowship in the
AID rican College of I-Iealth
CCl re Exec utives. Jackson
heads Me thodist's Pat ien t
Services Divi sion. the
hospita l' s largest di is ion,
with more than 3,600 em
ployees and an annual oper
ating budget of more than
$200 million.
.Jeanette Dansberry. OT
'59, i' a sup ' rvisor in the
Divisi on of Vocational Re
habil itation for lh Wiscon
sin Dep3rtment of Health
and Socia l Services. She has
worked for rhe State of Wis
consin for 26 years.

Sandra H. Phipps, PT
85, and her husb and , Ed
ward, announce the arri val of
their second child, Martin
Edward, who was born on
ovemb r, 27, 1991, weigh
ing eight pou nds an d two
ounces. He was welcomed
home by his sister, He len.
Gina M. Mu olino, PT
'87, 113S accepted an appoint
ment as adjunct ass istant
professor with the University
of Central Florida's Program
in Physi cal Therapy. She
also will practice with the
staff in physi cal thera py at a
spons med icine and indus
trial rehabilitation center in
Orlando.

L I E \1 () IH \ \I
David Apirion , Ph.D.,
professor o f mo lecular mi
crobio logy. died August 29 ,
1992, after slIffering a heart
attack pirion was cycling
on a tour in west St. Louis
County at the time of the
hea rt attack .
A hi ghly rega rded re
searcher in thc fi eld of mo
lec ular genetics and
espec ially RN A III tabolism,
Apirion had been a bculty
m mber at the School of
Medicine since 1965. Ile had
pub lished more than 175 pa
pers in his field and was the
recipient of many awards for
his work.
Apirion was active in his
synagog ue and vo lu nteered
in the Big Brothers/Big Sis
ters organization. At the
most recent Senior Olym

pics, held in St. Louis, he
wo n five meda ls in swim
ming and cycli ng event::; .
Among hi s su rvivors are a
daughter, Alison Apirion of
Clayton; two sons, Jonathan
of organton, NC. and
Mi ch ael of Los Angeles; and
several broth rs and si ten;,
all li ving in Lrael. Api rion
was born in Petah Ti kvah,
one of the first Jewish settle
ments in what later became
Israel. He was 57 years old .
A fund in his honor has
been estab l is hed. Contribu
ti ons may be sent to Wash
ington niversity School of
Med ici ne, Department f
Molecu la r Microbiology,
Box 823 0,660 S. Euc lid. St.
Loui s, MO 63 J 10, he fund
wi IJ be used for the purchase
or new books and journals
for the li brary and thc pres
ervati on of the rare an d hi s
torical book collecti on . •

This t!tree-dimellsional recollstructiol/ of a bundle of brain capillaries was bui lt up from more
than 700 e lectron micrographs . The reconstru ction , prepared by Lyndon S. lIibbard, Ph.D. , and
his colleagues in the Laboratory of Neurolmaging, ,vas created using computer programs to
al ign the images aDd to isolate the capillaries from surrounding tissues . The picture is a stereo
pair. By hol ding this page at arm' s length and gazing " through" it at a distant point, the viewer
may be able to fuse the two elements and perceive a single 3-D image.
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The three major candidates for president in 1992 appeared on Washington University's
hilltop campus on Sunday, October 11, to debate the issues in front of what was esti
mated to be one of the largest television audiences ever. The Athletic Complex's Field
House was transformed from a basketball court into a sound stage for the event, said by
its producer to be perhaps the most important 90 minutes of the entire campaign.

